EDGEWELL PERSONAL CARE CO
10-Ks and 10-Qs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________
FORM 10-Q
_______________________________
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
or
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from _______________ to _______________
Commission File Number: 001-15401
____________________________________________________________________________________________________________
EDGEWELL PERSONAL CARE COMPANY
(Exact name of registrant as specified in its charter)
|
Missouri
|
43-1863181
|
|
(State or other jurisdiction of incorporation or organization)
|
(I. R. S. Employer Identification No.)
|
|
|
|
|
1350 Timberlake Manor Parkway
|
|
|
Chesterfield, Missouri
|
63017
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
(314) 594-1900
|
|
|
(Registrant's telephone number, including area code)
|
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes
x
No
o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes
x
No
o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
|
x
|
Accelerated filer
|
o
|
|
|
|
|
|||
|
Non-accelerated filer
|
o
|
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
o
|
|
Emerging growth company
|
o
|
|||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
o
No
x
Indicate number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:
Common shares, $0.01 par value - 53,997,612 shares as of January 31, 2018.
1
EDGEWELL PERSONAL CARE COMPANY
INDEX TO FORM 10-Q
|
PART I.
|
FINANCIAL INFORMATION
|
|
|
Item 1.
|
Financial Statements (Unaudited).
|
|
|
Condensed Consolidated Statements of Earnings and Comprehensive Income for the three months ended December 31, 2017 and 2016.
|
||
|
Condensed Consolidated Balance Sheets as of December 31, 2017 and September 30, 2017.
|
||
|
Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2017 and 2016.
|
||
|
Notes to Condensed Consolidated Financial Statements.
|
||
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations.
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
|
|
Item 4.
|
Controls and Procedures.
|
|
|
PART II.
|
OTHER INFORMATION
|
|
|
Item 1.
|
Legal Proceedings.
|
|
|
Item 1A.
|
Risk Factors.
|
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds.
|
|
|
Item 3.
|
Defaults Upon Senior Securities.
|
|
|
Item 4.
|
Mine Safety Disclosures.
|
|
|
Item 5.
|
Other Information.
|
|
|
Item 6.
|
Exhibits.
|
|
|
SIGNATURE
|
||
2
EDGEWELL PERSONAL CARE COMPANY
(unaudited, in millions, except per share data)
|
|
Three Months Ended
December 31,
|
||||||
|
|
2017
|
2016
|
|||||
|
Net sales
|
$
|
468.3
|
|
$
|
485.0
|
|
|
|
Cost of products sold
|
268.0
|
|
257.0
|
|
|||
|
Gross profit
|
200.3
|
|
228.0
|
|
|||
|
Selling, general and administrative expense
|
97.2
|
|
93.8
|
|
|||
|
Advertising and sales promotion expense
|
49.0
|
|
50.6
|
|
|||
|
Research and development expense
|
16.1
|
|
16.3
|
|
|||
|
Gain on sale of Playtex gloves
|
(15.9
|
)
|
—
|
|
|||
|
Restructuring charges
|
—
|
|
6.9
|
|
|||
|
Interest expense associated with debt
|
17.8
|
|
17.4
|
|
|||
|
Other expense (income), net
|
3.0
|
|
(1.9
|
)
|
|||
|
Earnings before income taxes
|
33.1
|
|
44.9
|
|
|||
|
Income tax provision
|
26.4
|
|
11.4
|
|
|||
|
Net earnings
|
$
|
6.7
|
|
$
|
33.5
|
|
|
|
Earnings per share:
|
|||||||
|
Basic net earnings per share
|
$
|
0.12
|
|
$
|
0.58
|
|
|
|
Diluted net earnings per share
|
$
|
0.12
|
|
$
|
0.58
|
|
|
|
Statements of Comprehensive Income:
|
|||||||
|
Net earnings
|
$
|
6.7
|
|
$
|
33.5
|
|
|
|
Other comprehensive income (loss), net of tax
|
|||||||
|
Foreign currency translation adjustments
|
9.5
|
|
(38.7
|
)
|
|||
|
Pension and postretirement activity, net of tax of $0.3 and $1.9
|
0.4
|
|
3.9
|
|
|||
|
Deferred gain on hedging activity, net of tax of $0.1 and $4.1
|
0.2
|
|
7.9
|
|
|||
|
Total other comprehensive income (loss), net of tax
|
10.1
|
|
(26.9
|
)
|
|||
|
Total comprehensive income
|
$
|
16.8
|
|
$
|
6.6
|
|
|
See accompanying Notes to Condensed Consolidated Financial Statements.
3
EDGEWELL PERSONAL CARE COMPANY
(unaudited, in millions, except share data)
|
December 31,
2017 |
September 30,
2017 |
||||||
|
Assets
|
|||||||
|
Current assets
|
|
||||||
|
Cash and cash equivalents
|
$
|
529.9
|
|
$
|
502.9
|
|
|
|
Trade receivables, less allowance for doubtful accounts of $5.4 and $4.3
|
183.1
|
|
224.1
|
|
|||
|
Inventories
|
349.3
|
|
333.5
|
|
|||
|
Other current assets
|
118.3
|
|
125.7
|
|
|||
|
Total current assets
|
1,180.6
|
|
1,186.2
|
|
|||
|
Property, plant and equipment, net
|
441.9
|
|
453.4
|
|
|||
|
Goodwill
|
1,447.8
|
|
1,445.9
|
|
|||
|
Other intangible assets, net
|
1,068.6
|
|
1,071.7
|
|
|||
|
Other assets
|
33.6
|
|
31.6
|
|
|||
|
Total assets
|
$
|
4,172.5
|
|
$
|
4,188.8
|
|
|
|
Liabilities and Shareholders' Equity
|
|||||||
|
Current liabilities
|
|||||||
|
Current maturities of long-term debt
|
$
|
—
|
|
$
|
—
|
|
|
|
Notes payable
|
21.1
|
|
19.4
|
|
|||
|
Accounts payable
|
198.8
|
|
223.6
|
|
|||
|
Other current liabilities
|
225.5
|
|
281.4
|
|
|||
|
Total current liabilities
|
445.4
|
|
524.4
|
|
|||
|
Long-term debt
|
1,678.7
|
|
1,525.4
|
|
|||
|
Deferred income tax liabilities
|
143.9
|
|
181.8
|
|
|||
|
Other liabilities
|
248.7
|
|
215.5
|
|
|||
|
Total liabilities
|
2,516.7
|
|
2,447.1
|
|
|||
|
Shareholders' equity
|
|||||||
|
Preferred shares, $0.01 par value, 10,000,000 authorized; none issued or outstanding
|
—
|
|
—
|
|
|||
|
Common shares, $0.01 par value, 300,000,000 authorized; 65,251,989 issued; 54,151,058 and 56,017,537 outstanding
|
0.7
|
|
0.7
|
|
|||
|
Additional paid-in capital
|
1,620.7
|
|
1,623.4
|
|
|||
|
Retained earnings
|
969.2
|
|
952.9
|
|
|||
|
Common shares in treasury at cost, 11,100,931 and 9,234,452
|
(813.5
|
)
|
(703.9
|
)
|
|||
|
Accumulated other comprehensive loss
|
(121.3
|
)
|
(131.4
|
)
|
|||
|
Total shareholders' equity
|
1,655.8
|
|
1,741.7
|
|
|||
|
Total liabilities and shareholders' equity
|
$
|
4,172.5
|
|
$
|
4,188.8
|
|
|
See accompanying Notes to Condensed Consolidated Financial Statements.
4
EDGEWELL PERSONAL CARE COMPANY
(unaudited, in millions)
|
|
Three Months Ended
December 31,
|
||||||
|
|
2017
|
2016
|
|||||
|
Cash Flow from Operating Activities
|
|
|
|||||
|
Net earnings
|
$
|
6.7
|
|
$
|
33.5
|
|
|
|
Non-cash restructuring costs
|
—
|
|
1.7
|
|
|||
|
Depreciation and amortization
|
24.8
|
|
23.4
|
|
|||
|
Share-based compensation expense
|
4.8
|
|
5.7
|
|
|||
|
(Gain) / loss on sale of assets
|
(13.9
|
)
|
1.8
|
|
|||
|
Deferred income taxes
|
(28.9
|
)
|
(0.7
|
)
|
|||
|
Other, net
|
(4.8
|
)
|
(5.7
|
)
|
|||
|
Changes in operating assets and liabilities
|
(9.7
|
)
|
(111.6
|
)
|
|||
|
Net cash used by operating activities
|
(21.0
|
)
|
(51.9
|
)
|
|||
|
Cash Flow from Investing Activities
|
|||||||
|
Capital expenditures
|
(11.6
|
)
|
(13.7
|
)
|
|||
|
Acquisitions, net of cash acquired
|
—
|
|
(34.0
|
)
|
|||
|
Playtex gloves sale
|
19.0
|
|
—
|
|
|||
|
Proceeds from sale of assets
|
2.1
|
|
—
|
|
|||
|
Net cash from (used by) investing activities
|
9.5
|
|
(47.7
|
)
|
|||
|
Cash Flow from Financing Activities
|
|||||||
|
Cash proceeds from debt with original maturities greater than 90 days
|
253.0
|
|
146.0
|
|
|||
|
Cash payments on debt with original maturities greater than 90 days
|
(100.0
|
)
|
(287.0
|
)
|
|||
|
Net decrease in debt with original maturities of 90 days or less
|
(1.3
|
)
|
(0.4
|
)
|
|||
|
Common shares purchased
|
(115.2
|
)
|
(58.0
|
)
|
|||
|
Employee shares withheld for taxes
|
(2.0
|
)
|
(7.1
|
)
|
|||
|
Net cash from (used by) financing activities
|
34.5
|
|
(206.5
|
)
|
|||
|
Effect of exchange rate changes on cash
|
4.0
|
|
(14.3
|
)
|
|||
|
Net increase (decrease) in cash and cash equivalents
|
27.0
|
|
(320.4
|
)
|
|||
|
Cash and cash equivalents, beginning of period
|
502.9
|
|
738.9
|
|
|||
|
Cash and cash equivalents, end of period
|
$
|
529.9
|
|
$
|
418.5
|
|
|
See accompanying Notes to Condensed Consolidated Financial Statements.
5
EDGEWELL PERSONAL CARE COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, in millions, except per share data)
Background
Edgewell Personal Care Company, and its subsidiaries (collectively, "Edgewell" or the "Company"), is one of the world's largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. Edgewell has a portfolio of over
25
brands and a global footprint in more than
50
countries.
The Company conducts its business in the following four segments:
|
•
|
Wet Shave
consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams.
|
|
•
|
Sun and Skin Care
consists of Banana Boat® and Hawaiian Tropic® sun care products, Bulldog® men's skin care products, Wet Ones® wipes and Playtex® household gloves until the sale of the gloves business in October 2017. Refer to Note 2 for additional details on the sale of the Playtex household gloves business.
|
|
•
|
Feminine Care
includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand.
|
|
•
|
All Other
includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems.
|
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP"), under the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 20, 2017.
Recently Adopted Accounting Pronouncements.
In August 2014, the Financial Accounting Standards Board ("FASB") issued a new Accounting Standards Update ("ASU"), which requires management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued. This evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. The Company adopted this guidance as of October 1, 2017 and noted the adoption did not have an impact on the financial statements or the related disclosures.
In July 2015, the FASB issued a new ASU, which aligns the measurement of inventory under GAAP more closely with International Financial Reporting Standards. Under the new guidance, an entity that measures inventory using FIFO or average cost should measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.
The Company adopted this guidance on a prospective basis as of
October 1, 201
7 and noted the adoption did not have a material impact on the financial statements or the related disclosures.
6
In March 2016, the FASB issued an ASU which simplifies several aspects of the accounting for share-based payment transactions, including requiring excess tax benefits and tax deficiencies to be recognized as income tax benefits or expenses in the consolidated statement of earnings. The standard requires cash flows from excess tax benefits and deficiencies, previously classified as a financing activity, to be classified as an operating activity in the consolidated statement of cash flows. The Company adopted these provisions of the guidance prospectively in the first quarter of fiscal 2018. As a result, the Company recognized excess tax deficiencies of
$0.6
through income taxes during the first quarter of fiscal 2018 rather than additional paid-in capital. The excess tax deficiencies were recorded as an operating activity in the Condensed Consolidated Statement of Cash Flows during the first quarter of 2018. Also, as part of the adoption, a
$9.7
adjustment was recorded to increase retained earnings and deferred tax assets to recognize the cumulative amount of previously unrecognized excess tax benefits as of October 1, 2017. Additionally, the ASU requires the presentation of employee taxes paid when an employer withholds shares for tax withholding purposes to be presented as a financing activity in the statement of cash flows as opposed to as an operating activity. This aspect of the new guidance was required to be adopted retrospectively. As such,
$7.1
of cash outflows for tax withholding payments were reclassified from an operating activity to a financing activity in the Condensed Consolidated Statement of Cash Flows for the first quarter of fiscal 2017. Finally, under the ASU, the Company elected to record forfeitures as they occur. This election did not have a material impact on the financial statements.
Recently Issued Accounting Pronouncements.
In May 2014, the FASB issued an ASU, which provides a single comprehensive revenue recognition model for all contracts with customers to improve comparability within industries, across industries and across capital markets. During 2016, the FASB issued three ASUs, clarifying the revenue recognition implementation guidance on various topics included within the original ASU. The new guidance will be effective for the Company beginning October 1, 2018, with the option of using either a full retrospective or modified retrospective method. The Company is still evaluating the method of adoption.
During fiscal 2017, the Company established a cross-functional implementation team, including representatives from all of its businesses globally, to analyze the current processes in place for the recognition of revenue and identify potential differences that would result from application of the new guidance. This initial assessment includes analysis of significant types of arrangements, processes and systems, and reviews of representative contracts. Additionally, the Company has begun reviewing the enhanced disclosure requirements under the new standard. Revenues are primarily generated from the sale of finished products to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. While the assessment is not complete, the timing of revenue recognition is not expected to be materially impacted by the new standard. The Company is still assessing the impact of the standard on its consolidated financial statements and on related disclosures.
No other new accounting pronouncement issued or effective during the fiscal year which was not previously disclosed in our Annual Report on Form 10-K had or is expected to have a material impact on our consolidated financial statements or related disclosures.
On October 3, 2017, the Company entered into an agreement to sell its Playtex® gloves business to a household products company (the “Acquirer”) for
$19.0
to allow the Company to better focus and utilize its resources on its other product lines. The agreement also provided the Acquirer with indefinite and exclusive worldwide rights to the Playtex trademark for gloves. The sale was completed on October 26, 2017. Total assets sold were approximately
$3.1
resulting in a pre-tax gain on sale of
$15.9
.
Restructuring
In November 2012, the Company's Board of Directors (the "Board") authorized an enterprise-wide restructuring plan (the "Restructuring"). The Restructuring originally included several initiatives focused on reducing costs in general and administrative functions, as well as reducing manufacturing and operating costs associated with the Company's discontinued operations. In January 2014, the Board authorized an expansion of scope of the previously announced Restructuring, which included rationalization and streamlining of the Edgewell operating facilities and other cost saving initiatives. Restructuring charges have primarily related to plant closure, accelerated depreciation charges, severance and related benefit costs. Restructuring costs under this plan totaled
$170.1
. Due to an increase in Wet Shave footprint costs and a delay in the transition of manufacturing in the Company's Feminine Care segment from Montreal to Dover, Delaware, some anticipated savings are not expected to be realized until fiscal 2019. The Company does not expect costs in fiscal 2018 or in future periods to be material.
7
Expenses incurred under the Restructuring plan are reflected below, including the estimated impact of allocating such charges to segment results. Restructuring charges were only allocated to the Company's Wet Shave and Feminine Care segments for the three months ended December 31, 2016. The Company does not include restructuring costs in the results of its reportable segments.
|
Three Months Ended December 31, 2016
|
|||||||||||
|
Wet
Shave |
Feminine
Care |
Total
|
|||||||||
|
Restructuring
|
|||||||||||
|
Severance and related benefit costs
|
$
|
0.4
|
|
$
|
1.5
|
|
$
|
1.9
|
|
||
|
Asset impairment and accelerated depreciation
|
—
|
|
1.7
|
|
1.7
|
|
|||||
|
Consulting, program management and other exit costs
|
1.7
|
|
1.6
|
|
3.3
|
|
|||||
|
Total Restructuring
|
$
|
2.1
|
|
$
|
4.8
|
|
$
|
6.9
|
|
||
In addition, pre-tax costs of
$0.3
for the three months ended December 31, 2016, associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring were included in Cost of products sold.
During the first quarter of fiscal 2018, the Company made severance and related benefit payments of
$0.7
. The remaining restructuring accrual was
$1.7
for severance and related benefit costs as of December 31, 2017.
The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2017:
|
Utilized
|
|||||||||||||||||||||||
|
October 1, 2016
|
Charge to
Income |
Other
(1)
|
Cash
|
Non-Cash
|
September 30,
2017
|
||||||||||||||||||
|
Restructuring
|
|||||||||||||||||||||||
|
Severance and termination related costs
|
$
|
16.7
|
|
$
|
6.5
|
|
$
|
(0.3
|
)
|
$
|
(20.5
|
)
|
$
|
—
|
|
$
|
2.4
|
|
|||||
|
Asset impairment and accelerated depreciation
|
—
|
|
6.9
|
|
—
|
|
—
|
|
(6.9
|
)
|
—
|
|
|||||||||||
|
Other related costs
|
—
|
|
16.2
|
|
—
|
|
(16.2
|
)
|
—
|
|
—
|
|
|||||||||||
|
Total Restructuring
|
$
|
16.7
|
|
$
|
29.6
|
|
$
|
(0.3
|
)
|
$
|
(36.7
|
)
|
$
|
(6.9
|
)
|
$
|
2.4
|
|
|||||
|
(1)
|
Includes the impact of currency translation.
|
For the three months ended December 31, 2017, the Company had income tax expense of
$26.4
on Earnings before income taxes of
$33.1
. The effective tax rate for the
three months ended December 31, 2017
was
79.8%
. The difference between the federal statutory rate and the effective rate is primarily due to a
$16.2
net transitional charge resulting from the enactment of The Tax Cuts and Jobs Act ("the Tax Act"), as discussed below. The rate was also affected by unfavorable tax adjustments, including the impact of the new share-based payment guidance and changes to prior year provision estimates, which increased the effective rate by
5%
.
For the three months ended December 31, 2016, the Company had income tax expense of
$11.4
on Earnings before income taxes of
$44.9
. The effective tax rate for the three months ended December 31, 2016 was
25.4%
. The difference between the federal statutory rate and the effective rate was due to a higher mix of earnings in lower tax rate jurisdictions and was favorably impacted by Spin costs and Restructuring charges in higher tax rate jurisdictions. In addition, the effective tax rate was impacted by favorable tax adjustments, which reduced the effective rate by approximately
4%
.
8
U.S. Tax Reform
On December 22, 2017, the U.S. government enacted the Tax Act. This new comprehensive tax legislation reduces the U.S. federal corporate tax rate from
35%
to
21%
but also limits and/or eliminates certain deductions while creating new taxes on certain foreign sourced earnings. Since the Company has a September 30 fiscal year end, the lower U.S. corporate income tax rate will be phased in, resulting in a blended U.S. statutory federal rate of approximately
24.5%
for the fiscal year ending September 30, 2018 and
21%
for subsequent fiscal years. The reduction in the U.S. corporate tax rate requires the Company to remeasure its U.S. deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which can be
24.5%
or
21%
. The Tax Act also imposed a one-time transition tax on historical earnings of certain foreign subsidiaries that were not previously taxed by the U.S.
Due to the Company’s fiscal year end, certain tax provisions of the new Tax Act will impact the Company in fiscal 2018 while others will be effective in subsequent years. For the quarter ended December 31, 2017 (period of enactment), the estimated impact of the one-time transition tax on foreign earnings was
$97.2
, offset by the estimated benefit of remeasurement of U.S. deferred tax assets and liabilities of
$81
. The net impact of these transitional provisions resulted in a net charge of
$16.2
for the quarter, which was included as a component of income tax expense. The Company has tax loss carryforwards and tax credits, a portion of which are expected be used to partially offset amounts payable over 8 years related to the one-time transition tax on foreign earnings.
The tax law changes included in the Tax Act are broad and complex. The estimates of the transition impact of the Tax Act, as discussed above, are provisional. The final impact may differ from those estimates, possibly materially, due to, among other things, changes in interpretation of the Tax Act, legislative action to address questions that arise because of the Tax Act, changes in accounting standards for income taxes or related interpretations in response to the Tax Act, or updates or changes to estimates the Company used to calculate the transition impacts, including impacts from changes to earnings estimates, foreign income tax estimates and foreign exchange rates. The Securities and Exchange Committee ("SEC") has issued rules under SAB 118 that would allow for a measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts.
The Company generally repatriates a portion of current year earnings from select non-US subsidiaries only if the economic cost of the repatriation is not considered material. As a result of the Tax Act, the Company expects to repatriate a significant amount of cash from foreign subsidiaries. The Company is currently evaluating the amount and expected uses of repatriated cash. The Company does not expect the incremental cost of repatriating cash to be material.
Basic earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted earnings per share is based on the number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent ("RSE") awards.
Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation:
|
Three Months Ended
December 31,
|
|||||
|
|
2017
|
2016
|
|||
|
Basic weighted-average shares outstanding
|
55.4
|
|
57.7
|
|
|
|
Effect of dilutive securities:
|
|||||
|
RSE awards
|
0.2
|
|
0.4
|
|
|
|
Total dilutive securities
|
0.2
|
|
0.4
|
|
|
|
Diluted weighted-average shares outstanding
|
55.6
|
|
58.1
|
|
|
For the
three months ended December 31, 2017
and 2016, the calculation of diluted weighted-average shares outstanding excludes
0.6
of share options because the effect of including these awards was anti-dilutive. For the three months ended December 31, 2017 and 2016, the number of RSE awards considered anti-dilutive was immaterial.
9
The following table sets forth goodwill by segment:
|
Wet
Shave |
Sun and Skin
Care |
Feminine
Care |
All
Other |
Total
|
|||||||||||||||
|
Balance at October 1, 2017
|
$
|
971.2
|
|
$
|
195.6
|
|
$
|
209.5
|
|
$
|
69.6
|
|
$
|
1,445.9
|
|
||||
|
Cumulative translation adjustment
|
2.1
|
|
0.1
|
|
(0.3
|
)
|
—
|
|
1.9
|
|
|||||||||
|
Balance at December 31, 2017
|
$
|
973.3
|
|
$
|
195.7
|
|
$
|
209.2
|
|
$
|
69.6
|
|
$
|
1,447.8
|
|
||||
Total amortizable intangible assets were as follows:
|
December 31, 2017
|
September 30, 2017
|
||||||||||||||||||||||
|
Gross
Carrying Amount |
Accumulated
Amortization |
Net
|
Gross
Carrying Amount |
Accumulated
Amortization |
Net
|
||||||||||||||||||
|
Trade names and brands
|
$
|
189.3
|
|
$
|
18.3
|
|
$
|
171.0
|
|
$
|
188.6
|
|
$
|
16.0
|
|
$
|
172.6
|
|
|||||
|
Technology and patents
|
78.0
|
|
75.3
|
|
2.7
|
|
77.9
|
|
74.4
|
|
3.5
|
|
|||||||||||
|
Customer related and other
|
151.6
|
|
91.2
|
|
60.4
|
|
151.5
|
|
89.8
|
|
61.7
|
|
|||||||||||
|
Total amortizable intangible assets
|
$
|
418.9
|
|
$
|
184.8
|
|
$
|
234.1
|
|
$
|
418.0
|
|
$
|
180.2
|
|
$
|
237.8
|
|
|||||
Amortization expense was
$4.4
and
$4.0
for the
three months ended December 31, 2017
and 2016, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2018 and for fiscal 2019, 2020, 2021, 2022 and 2023 is
$11.7
,
$14.8
,
$14.2
,
$13.6
,
$13.5
and
$13.5
, respectively, and
$152.8
thereafter.
The Company had indefinite-lived intangible assets of
$834.5
(
$185.1
in Wet Shave,
$475.7
in Sun and Skin Care,
$29.9
in Feminine Care and
$143.8
in All Other) at
December 31, 2017
,
an increase
of
$0.6
from September 30, 2017, related to changes in foreign currency translation rates.
Goodwill and intangible assets deemed to have an indefinite life are not amortized, but reviewed annually during the fourth fiscal quarter for impairment of value or when indicators of a potential impairment are present. The Company continuously monitors events which could trigger an interim impairment analysis, such as changing business conditions and environmental factors. The Company's stock price has declined since September 30, 2017. A prolonged decrease in the Company's stock price could be an indication of a triggering event. An interim impairment analysis may indicate that carrying amounts of goodwill and other intangible assets require adjustment or that remaining useful lives should be revised. Refer to the sensitivity analysis in Note 8 to the Company's audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 20, 2017.
During fiscal 2017, the Company recorded impairment charges of
$312.0
and
$7.0
on its Playtex and Edge brand names, respectively. The impairment of Playtex and Edge in fiscal 2017 was the result of intense competition in the Feminine Care and Wet Shave segments which resulted in decreased market share. Based on the impairment taken and continued competitive pressure on the Playtex and Edge brands, the intangible assets associated with the brand names were converted to definite-lived assets as of July 1, 2017 and assigned a useful life of
20
years. The conversion of the Playtex and Edge brand names to definite-lived intangible assets increased amortization expense by
$1.8
for the three months ended December 31, 2017.
10
|
December 31,
2017 |
September 30,
2017 |
||||||
|
Inventories
|
|
|
|||||
|
Raw materials and supplies
|
$
|
52.2
|
|
$
|
50.6
|
|
|
|
Work in process
|
61.3
|
|
60.9
|
|
|||
|
Finished products
|
235.8
|
|
222.0
|
|
|||
|
Total inventories
|
$
|
349.3
|
|
$
|
333.5
|
|
|
|
Other Current Assets
|
|
||||||
|
Miscellaneous receivables
|
$
|
13.7
|
|
$
|
16.9
|
|
|
|
Prepaid expenses
|
64.8
|
|
55.6
|
|
|||
|
Value added tax collectible from customers
|
20.3
|
|
25.2
|
|
|||
|
Income taxes receivable
|
16.7
|
|
24.7
|
|
|||
|
Other
|
2.8
|
|
3.3
|
|
|||
|
Total other current assets
|
$
|
118.3
|
|
$
|
125.7
|
|
|
|
Property, Plant and Equipment
|
|
|
|||||
|
Land
|
$
|
19.5
|
|
$
|
19.3
|
|
|
|
Buildings
|
142.5
|
|
139.1
|
|
|||
|
Machinery and equipment
|
956.3
|
|
947.4
|
|
|||
|
Capitalized software costs
|
45.3
|
|
42.3
|
|
|||
|
Construction in progress
|
41.8
|
|
49.7
|
|
|||
|
Total gross property, plant and equipment
|
1,205.4
|
|
1,197.8
|
|
|||
|
Accumulated depreciation and amortization
|
(763.5
|
)
|
(744.4
|
)
|
|||
|
Total property, plant and equipment, net
|
$
|
441.9
|
|
$
|
453.4
|
|
|
|
Other Current Liabilities
|
|
|
|||||
|
Accrued advertising, sales promotion and allowances
|
$
|
41.4
|
|
$
|
32.2
|
|
|
|
Accrued trade allowances
|
21.2
|
|
24.6
|
|
|||
|
Accrued salaries, vacations and incentive compensation
|
27.1
|
|
40.6
|
|
|||
|
Income taxes payable
|
10.6
|
|
18.3
|
|
|||
|
Returns reserve
|
27.3
|
|
53.3
|
|
|||
|
Restructuring reserve
|
1.7
|
|
3.0
|
|
|||
|
Value added tax payable
|
5.1
|
|
5.8
|
|
|||
|
Deferred compensation
|
15.3
|
|
13.8
|
|
|||
|
Other
|
75.8
|
|
89.8
|
|
|||
|
Total other current liabilities
|
$
|
225.5
|
|
$
|
281.4
|
|
|
|
Other Liabilities
|
|
|
|||||
|
Pensions and other retirement benefits
|
$
|
106.6
|
|
$
|
109.4
|
|
|
|
Deferred compensation
|
42.1
|
|
47.3
|
|
|||
|
Long-term income taxes payable
|
41.4
|
|
—
|
|
|||
|
Other non-current liabilities
|
58.6
|
|
58.8
|
|
|||
|
Total other liabilities
|
$
|
248.7
|
|
$
|
215.5
|
|
|
11
On September 15, 2017, the Company entered into a
$150
uncommitted master accounts receivable purchase agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser. Transfers under this agreement are accounted for as sales of receivables, resulting in the receivables being de-recognized from the consolidated balance sheet. As of December 31, 2017, the discount rate used to determine the purchase price for the subject receivables is based upon LIBOR plus a margin applicable to the specified obligor.
Account receivables sold under this agreement for the quarter ended December 31, 2017 were
$210.1
. The trade receivables sold that remained outstanding under this agreement as of December 31, 2017 and September 30, 2017 were
$74.6
and
$81.7
, respectively. The dilution reserve, which represents the Company's retained interest in sold receivables, was
$7.5
and
$8.2
as of December 31, 2017 and September 30, 2017, respectively, and was recognized on the Consolidated Balance Sheets as a receivable. The difference between the carrying amount of the trade receivables sold and the sum of the cash received was recorded as a loss on sale of receivables in Other expense (income), net in the Consolidated Statement of Earnings. For the three months ended December 31, 2017, the loss on sale of trade receivables was
$0.4
.
The detail of long-term debt was as follows:
|
December 31,
2017 |
September 30,
2017 |
||||||
|
Senior notes, fixed interest rate of 4.7%, due 2021, net
(1)
|
$
|
598.4
|
|
$
|
598.3
|
|
|
|
Senior notes, fixed interest rate of 4.7%, due 2022, net
(1) (2)
|
497.6
|
|
497.4
|
|
|||
|
U.S. revolving credit facility due 2020
|
398.0
|
|
245.0
|
|
|||
|
Term loan, due 2019, net
(1)
|
184.7
|
|
184.7
|
|
|||
|
Total long-term debt, including current maturities
|
1,678.7
|
|
1,525.4
|
|
|||
|
Less current portion
|
—
|
|
—
|
|
|||
|
Total long-term debt
|
$
|
1,678.7
|
|
$
|
1,525.4
|
|
|
|
(1)
|
At December 31, 2017
, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of
$1.6
,
$1.8
and
$0.3
, respectively. At September 30, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of
$1.7
,
$1.9
and
$0.3
, respectively.
|
|
(2)
|
At December 31, 2017
and September 30, 2017, the balance for the senior notes due 2022 was reflected net of discount of
$0.6
and
$0.7
, respectively.
|
The Company had outstanding, variable-rate international borrowings, recorded in Notes payable, of
$21.1
and
$19.4
as of December 31, 2017
and
September 30, 2017
, respectively.
12
The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries, which are included in the information presented below. The plans provide retirement benefits based on years of service and earnings. The Company also sponsors or participates in a number of other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below.
The Company's net periodic pension and postretirement benefit (credit) cost for these plans was as follows:
|
Three Months Ended
December 31,
|
|||||||
|
|
2017
|
2016
|
|||||
|
Service cost
|
$
|
1.5
|
|
$
|
1.8
|
|
|
|
Interest cost
|
4.3
|
|
3.8
|
|
|||
|
Expected return on plan assets
|
(7.9
|
)
|
(7.9
|
)
|
|||
|
Recognized net actuarial loss
|
1.1
|
|
1.5
|
|
|||
|
Settlement loss recognized
|
—
|
|
0.3
|
|
|||
|
Net periodic (benefit) cost
|
$
|
(1.0
|
)
|
$
|
(0.5
|
)
|
|
In January 2018, the Board approved an authorization to repurchase up to
10.0
shares of the Company's common stock, replacing the previous stock repurchase authorization from May 2015, when the Board approved an authorization to repurchase up to
10.0
shares of the Company's common stock. During the
three months ended December 31, 2017
, the Company repurchased
1.9
shares of its common stock for
$115.2
, all of which were purchased under the previous authorization from May 2015. The full
10.0
shares authorized by the Board in January 2018 are available for future share repurchases. Any future share repurchases would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs and other factors.
During the
three months ended December 31, 2017
, the Company paid
$0.1
cash dividends related to the vesting of RSE awards, which had been declared and accrued during prior fiscal years. The Company has not declared any dividends since the third quarter of fiscal 2015, and does not currently intend to declare dividends in the foreseeable future.
The following table presents the changes in accumulated other comprehensive (loss) income ("AOCI"), net of tax, by component:
|
Foreign
Currency Translation Adjustments |
Pension and
Post-retirement Activity |
Hedging
Activity |
Total
|
||||||||||||
|
Balance at October 1, 2017
|
$
|
(29.0
|
)
|
$
|
(101.3
|
)
|
$
|
(1.1
|
)
|
$
|
(131.4
|
)
|
|||
|
OCI before reclassifications
(1)
|
9.5
|
|
(0.3
|
)
|
(0.3
|
)
|
8.9
|
|
|||||||
|
Reclassifications to earnings
|
—
|
|
0.7
|
|
0.5
|
|
1.2
|
|
|||||||
|
Balance at December 31, 2017
|
$
|
(19.5
|
)
|
$
|
(100.9
|
)
|
$
|
(0.9
|
)
|
$
|
(121.3
|
)
|
|||
|
Foreign
Currency Translation Adjustments |
Pension and
Post-retirement Activity |
Hedging
Activity |
Total
|
||||||||||||
|
Balance at October 1, 2016
|
$
|
(68.1
|
)
|
$
|
(126.3
|
)
|
$
|
(2.8
|
)
|
$
|
(197.2
|
)
|
|||
|
OCI before reclassifications
(1)
|
(38.7
|
)
|
2.7
|
|
7.7
|
|
(28.3
|
)
|
|||||||
|
Reclassifications to earnings
|
—
|
|
1.2
|
|
0.2
|
|
1.4
|
|
|||||||
|
Balance at December 31, 2016
|
$
|
(106.8
|
)
|
$
|
(122.4
|
)
|
$
|
5.1
|
|
$
|
(224.1
|
)
|
|||
13
|
(1)
|
OCI is defined as other comprehensive income (loss).
|
The following table presents the reclassifications out of AOCI:
|
For the Three Months Ended
December 31, |
Affected Line Item in the
Condensed Consolidated
Statements of Earnings
|
|||||||||
|
Details of AOCI Components
|
2017
|
2016
|
||||||||
|
Loss / (gain) on cash flow hedges
|
||||||||||
|
Foreign exchange contracts
|
$
|
0.7
|
|
$
|
0.3
|
|
Other (income) expense, net
|
|||
|
0.7
|
|
0.3
|
|
Total before tax
|
||||||
|
(0.2
|
)
|
(0.1
|
)
|
Tax expense
|
||||||
|
0.5
|
|
0.2
|
|
Net of tax
|
||||||
|
Amortization of defined benefit pension and postretirement items
|
||||||||||
|
Actuarial losses
|
1.1
|
|
1.5
|
|
(1)
|
|||||
|
Settlement loss recognized
|
—
|
|
0.3
|
|
(1)
|
|||||
|
1.1
|
|
1.8
|
|
Total before tax
|
||||||
|
(0.4
|
)
|
(0.6
|
)
|
Tax expense
|
||||||
|
0.7
|
|
1.2
|
|
Net of tax
|
||||||
|
Total reclassifications for the period
|
$
|
1.2
|
|
$
|
1.4
|
|
Net of tax
|
|||
|
(1)
|
These AOCI components are included in the computation of net periodic (benefit) cost. See Note 10 of Notes to Condensed Consolidated Financial Statements.
|
At times, the Company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties and its counterparty netting arrangements. The section below outlines the types of derivatives that existed at
December 31, 2017
and
September 30, 2017
, as well as the Company's objectives and strategies for holding derivative instruments.
Foreign Currency Risk
A significant share of the Company's sales are tied to currencies other than the U.S. dollar, the Company's reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact to reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the Euro, the Japanese Yen, the British Pound, the Canadian Dollar, the Czech Koruna and the Australian Dollar.
Additionally, the Company's foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary's local currency at the end of each period. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary's local currency results in an exchange gain or loss recorded in Other expense (income), net. The primary currency to which the Company's foreign subsidiaries are exposed is the U.S. dollar.
14
Cash Flow Hedges
At December 31, 2017
, the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective for accounting purposes in offsetting the associated risk.
The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had unrealized pre-tax losses of
$1.3
and
$1.6
at
December 31, 2017
and
September 30, 2017
, respectively, on these forward currency contracts accounted for as cash flow hedges, which are included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at
December 31, 2017
levels over the next twelve months, the majority of the pre-tax loss included in AOCI at
December 31, 2017
is expected to be included in Other (income) expense, net. Contract maturities for these hedges extend into fiscal 2019. There were
63
open foreign currency contracts at
December 31, 2017
with a total notional value of
$129.8
.
Derivatives not Designated as Hedges
The Company entered into foreign currency derivative contracts which are not designated as cash flow hedges for accounting purposes to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures, thus they are not subject to significant market risk. The change in estimated fair value of the foreign currency contracts for the
three months ended December 31, 2017
resulted in a loss of
$0.2
, compared to a gain of
$3.5
for the three months ended December 31, 2016, and was recorded in Other expense (income), net in the Condensed Consolidated Statements of Earnings. There were
six
open foreign currency derivative contracts, which were not designated as cash flow hedges at
December 31, 2017
, with a total notional value of
$71.0
.
The following table provides estimated fair values of derivative instruments:
|
Fair Value of Asset (Liability)
(1)
|
|||||||
|
December 31,
2017
|
September 30,
2017
|
||||||
|
Derivatives designated as cash flow hedging relationships:
|
|||||||
|
Foreign currency contracts
|
$
|
(1.3
|
)
|
$
|
(1.6
|
)
|
|
|
Derivatives not designated as cash flow hedging relationships:
|
|||||||
|
Foreign currency contracts
|
$
|
(0.7
|
)
|
$
|
0.4
|
|
|
|
(1)
|
All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.
|
The following table provides the amounts of gains and losses on derivative instruments:
|
Three Months Ended December 31,
|
|||||||
|
2017
|
2016
|
||||||
|
Derivatives designated as cash flow hedging relationships:
|
|||||||
|
Foreign currency contracts
|
|
||||||
|
(Loss) gain recognized in OCI
(1)
|
$
|
(0.4
|
)
|
$
|
11.7
|
|
|
|
Loss (gain) reclassified from AOCI into income (effective portion)
(1) (2)
|
0.7
|
|
0.3
|
|
|||
|
Derivatives not designated as cash flow hedging relationships:
|
|||||||
|
Foreign currency contracts
|
|||||||
|
Loss (gain) recognized in income
(2)
|
$
|
0.2
|
|
$
|
(3.5
|
)
|
|
|
(1)
|
Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.
|
|
(2)
|
Loss (gain) was recorded in Other (income) expense, net.
|
15
The following table provides financial assets and liabilities for balance sheet offsetting:
|
At December 31, 2017
|
At September 30, 2017
|
||||||||||||||
|
Assets
(1)
|
Liabilities
(2)
|
Assets
(1)
|
Liabilities
(2)
|
||||||||||||
|
Foreign currency contracts
|
|||||||||||||||
|
Gross amounts of recognized assets (liabilities)
|
$
|
1.3
|
|
$
|
(3.3
|
)
|
$
|
2.5
|
|
$
|
(3.7
|
)
|
|||
|
Gross amounts offset in the balance sheet
|
(0.1
|
)
|
0.1
|
|
(0.1
|
)
|
0.1
|
|
|||||||
|
Net amounts of assets (liabilities) presented in the balance sheet
|
$
|
1.2
|
|
$
|
(3.2
|
)
|
$
|
2.4
|
|
$
|
(3.6
|
)
|
|||
|
(1)
|
All derivative assets are presented in Other current assets or Other assets.
|
|
(2)
|
All derivative liabilities are presented in Other current liabilities or Other liabilities.
|
Fair Value Hierarchy
Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs reflecting the reporting entity's own assumptions or external inputs from inactive markets.
Under the fair value accounting guidance hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy:
|
December 31,
2017 |
September 30,
2017 |
||||||
|
Liabilities at estimated fair value:
|
|
|
|||||
|
Deferred compensation
|
$
|
(57.4
|
)
|
$
|
(60.9
|
)
|
|
|
Derivatives - foreign currency contracts
|
(2.0
|
)
|
(1.2
|
)
|
|||
|
Net liabilities at estimated fair value
|
$
|
(59.4
|
)
|
$
|
(62.1
|
)
|
|
At December 31, 2017
, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates and remaining maturities. The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan.
At December 31, 2017
and
September 30, 2017
, the Company had no level 1 or level 3 financial assets or liabilities, other than pension plan assets.
At December 31, 2017
and
September 30, 2017
, the fair market value of fixed rate long-term debt was
$1,123.0
and
$1,143.8
, respectively, compared to its carrying value of
$1,096.0
and $
1,095.7
, respectively. The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of variable-rate debt, excluding revolving credit facilities, which consists of bank debt, was
$185.0
compared to its carrying value of
$184.7
at December 31, 2017 and September 30, 2017. The estimated fair value was equal to the face value of the debt. The estimated fair value of long-term debt, excluding revolving credit facilities, have been determined based on level 2 inputs.
Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Company's revolving credit facilities, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings and the revolving credit agreements have been determined based on level 2 inputs.
16
The Company and its affiliates are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, if the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to the Company's financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.
The Company conducts its business in the following four segments:
|
•
|
Wet Shave
consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams.
|
|
•
|
Sun and Skin Care
consists of Banana Boat® and Hawaiian Tropic® sun care products, Bulldog® men's skin care products, Wet Ones® wipes and Playtex® household gloves until the sale of the gloves business in October 2017. Refer to Note 2 for additional details on the sale of the Playtex household gloves business.
|
|
•
|
Feminine Care
includes tampons, pads and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand.
|
|
•
|
All Other
includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems.
|
Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, costs associated with restructuring initiatives, the gain on the sale of the Playtex gloves business and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance.
The Company's operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and in most cases a combined sales force and management teams. The Company applies a fully allocated cost basis, in which shared business functions are allocated between the segments. Such allocations are estimates, and do not represent the costs of such services if performed on a stand-alone basis.
17
Segment net sales and profitability are presented below:
|
|
Three Months Ended
December 31,
|
||||||
|
|
2017
|
2016
|
|||||
|
Net Sales
|
|
||||||
|
Wet Shave
|
$
|
294.1
|
|
$
|
306.2
|
|
|
|
Sun and Skin Care
|
59.1
|
|
57.6
|
|
|||
|
Feminine Care
|
82.6
|
|
89.1
|
|
|||
|
All Other
|
32.5
|
|
32.1
|
|
|||
|
Total net sales
|
$
|
468.3
|
|
$
|
485.0
|
|
|
|
Segment Profit
|
|
||||||
|
Wet Shave
|
$
|
54.7
|
|
$
|
72.0
|
|
|
|
Sun and Skin Care
|
(6.1
|
)
|
0.8
|
|
|||
|
Feminine Care
|
5.0
|
|
8.3
|
|
|||
|
All Other
|
7.2
|
|
6.9
|
|
|||
|
Total segment profit
|
60.8
|
|
88.0
|
|
|||
|
General corporate and other expenses
|
(18.4
|
)
|
(16.4
|
)
|
|||
|
Gain on sale of Playtex gloves
|
15.9
|
|
—
|
|
|||
|
Restructuring and related costs
(1)
|
—
|
|
(7.2
|
)
|
|||
|
Amortization of intangibles
|
(4.4
|
)
|
(4.0
|
)
|
|||
|
Interest and other expense, net
|
(20.8
|
)
|
(15.5
|
)
|
|||
|
Total earnings before income taxes
|
$
|
33.1
|
|
$
|
44.9
|
|
|
|
(1)
|
Includes pre-tax Cost of products sold of
$0.3
for the three months ended December 31, 2016, associated with obsolescence charges related to the exit of certain non-core product lines as a part of restructuring.
|
Supplemental product information is presented below for net sales:
|
Three Months Ended
December 31, |
|||||||
|
|
2017
|
2016
|
|||||
|
Razors and blades
|
$
|
261.5
|
|
$
|
271.3
|
|
|
|
Tampons, pads and liners
|
82.6
|
|
89.1
|
|
|||
|
Sun care products
|
38.3
|
|
37.7
|
|
|||
|
Shaving gels and creams
|
32.6
|
|
34.9
|
|
|||
|
Infant care and other
|
32.5
|
|
32.1
|
|
|||
|
Skin care products
|
20.8
|
|
19.9
|
|
|||
|
Total net sales
|
$
|
468.3
|
|
$
|
485.0
|
|
|
18
The Company's senior notes issued in May 2011 and May 2012 (collectively, the "Notes") are fully and unconditionally guaranteed on a joint and several basis by the Company's existing and future direct and indirect domestic subsidiaries that are guarantors of any of the Company's credit agreements or other indebtedness for borrowed money (the "Guarantors"). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company's obligations under the Notes and substantially all of the Company's other outstanding indebtedness. The Company's subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company's other indebtedness (collectively, the "Non-Guarantors"), do not guarantee the Notes. The subsidiary guarantee with respect to the Notes is subject to release upon sale of all of the capital stock of the Subsidiary Guarantor; if the guarantee under the Company's credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture.
Set forth below are the condensed consolidating financial statements presenting the results of operations, financial position and cash flows of the Parent Company, Edgewell Personal Care Company, the Guarantors on a combined basis, the Non-Guarantors on a combined basis and eliminations necessary to arrive at the information for the Company, as reported on a consolidated basis. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among the Parent Company, the Guarantors and the Non-Guarantors.
19
EDGEWELL PERSONAL CARE COMPANY
CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME
Three Months Ended December 31, 2017
|
Parent Company
|
Guarantors
|
Non-Guarantors
|
Eliminations
|
Total
|
|||||||||||||||
|
Net sales
|
$
|
—
|
|
$
|
312.1
|
|
$
|
227.5
|
|
$
|
(71.3
|
)
|
$
|
468.3
|
|
||||
|
Cost of products sold
|
—
|
|
194.8
|
|
144.5
|
|
(71.3
|
)
|
268.0
|
|
|||||||||
|
Gross profit
|
—
|
|
117.3
|
|
83.0
|
|
—
|
|
200.3
|
|
|||||||||
|
Selling, general and administrative expense
|
—
|
|
61.9
|
|
35.3
|
|
—
|
|
97.2
|
|
|||||||||
|
Advertising and sales promotion expense
|
—
|
|
26.5
|
|
22.5
|
|
—
|
|
49.0
|
|
|||||||||
|
Research and development expense
|
—
|
|
16.1
|
|
—
|
|
—
|
|
16.1
|
|
|||||||||
|
Gain on sale of Playtex gloves
|
—
|
|
(15.9
|
)
|
—
|
|
—
|
|
(15.9
|
)
|
|||||||||
|
Interest expense associated with debt
|
13.4
|
|
4.2
|
|
0.2
|
|
—
|
|
17.8
|
|
|||||||||
|
Other expense, net
|
—
|
|
0.4
|
|
2.6
|
|
—
|
|
3.0
|
|
|||||||||
|
Intercompany service fees
|
—
|
|
(6.9
|
)
|
6.9
|
|
—
|
|
—
|
|
|||||||||
|
Equity in earnings of subsidiaries
|
(16.5
|
)
|
(12.8
|
)
|
—
|
|
29.3
|
|
—
|
|
|||||||||
|
Earnings before income taxes
|
3.1
|
|
43.8
|
|
15.5
|
|
(29.3
|
)
|
33.1
|
|
|||||||||
|
Income tax (benefit) provision
|
(3.6
|
)
|
27.3
|
|
2.7
|
|
—
|
|
26.4
|
|
|||||||||
|
Net earnings
|
$
|
6.7
|
|
$
|
16.5
|
|
$
|
12.8
|
|
$
|
(29.3
|
)
|
$
|
6.7
|
|
||||
|
Statements of Comprehensive Income:
|
|||||||||||||||||||
|
Net earnings
|
$
|
6.7
|
|
$
|
16.5
|
|
$
|
12.8
|
|
$
|
(29.3
|
)
|
$
|
6.7
|
|
||||
|
Other comprehensive income, net of tax
|
10.1
|
|
10.1
|
|
9.6
|
|
(19.7
|
)
|
10.1
|
|
|||||||||
|
Total comprehensive income
|
$
|
16.8
|
|
$
|
26.6
|
|
$
|
22.4
|
|
$
|
(49.0
|
)
|
$
|
16.8
|
|
||||
20
EDGEWELL PERSONAL CARE COMPANY
CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME
Three Months Ended December 31, 2016
|
Parent Company
|
Guarantors
|
Non-Guarantors
|
Eliminations
|
Total
|
|||||||||||||||
|
Net sales
|
$
|
—
|
|
$
|
342.9
|
|
$
|
232.3
|
|
$
|
(90.2
|
)
|
$
|
485.0
|
|
||||
|
Cost of products sold
|
—
|
|
204.5
|
|
142.7
|
|
(90.2
|
)
|
257.0
|
|
|||||||||
|
Gross profit
|
—
|
|
138.4
|
|
89.6
|
|
—
|
|
228.0
|
|
|||||||||
|
Selling, general and administrative expense
|
—
|
|
58.7
|
|
35.1
|
|
—
|
|
93.8
|
|
|||||||||
|
Advertising and sales promotion expense
|
—
|
|
30.2
|
|
20.4
|
|
—
|
|
50.6
|
|
|||||||||
|
Research and development expense
|
—
|
|
16.0
|
|
0.3
|
|
—
|
|
16.3
|
|
|||||||||
|
Restructuring charges
|
—
|
|
2.7
|
|
4.2
|
|
—
|
|
6.9
|
|
|||||||||
|
Interest expense associated with debt
|
13.4
|
|
3.3
|
|
0.7
|
|
—
|
|
17.4
|
|
|||||||||
|
Other expense (income), net
|
—
|
|
0.4
|
|
(2.3
|
)
|
—
|
|
(1.9
|
)
|
|||||||||
|
Intercompany service fees
|
—
|
|
(4.4
|
)
|
4.4
|
|
—
|
|
—
|
|
|||||||||
|
Equity in earnings of subsidiaries
|
(41.9
|
)
|
(21.1
|
)
|
—
|
|
63.0
|
|
—
|
|
|||||||||
|
Earnings before income taxes
|
28.5
|
|
52.6
|
|
26.8
|
|
(63.0
|
)
|
44.9
|
|
|||||||||
|
Income tax (benefit) provision
|
(5.0
|
)
|
10.9
|
|
5.5
|
|
—
|
|
11.4
|
|
|||||||||
|
Net earnings
|
$
|
33.5
|
|
$
|
41.7
|
|
$
|
21.3
|
|
$
|
(63.0
|
)
|
$
|
33.5
|
|
||||
|
Statements of Comprehensive Income:
|
|||||||||||||||||||
|
Net earnings
|
33.5
|
|
41.7
|
|
21.3
|
|
(63.0
|
)
|
33.5
|
|
|||||||||
|
Other comprehensive (loss), net of tax
|
(26.9
|
)
|
(3.2
|
)
|
(27.8
|
)
|
31.0
|
|
(26.9
|
)
|
|||||||||
|
Total comprehensive income (loss)
|
$
|
6.6
|
|
$
|
38.5
|
|
$
|
(6.5
|
)
|
$
|
(32.0
|
)
|
$
|
6.6
|
|
||||
21
EDGEWELL PERSONAL CARE COMPANY
CONDENSED CONSOLIDATING BALANCE SHEETS
December 31, 2017
|
Parent Company
|
Guarantors
|
Non-Guarantors
|
Eliminations
|
Total
|
|||||||||||||||
|
Assets
|
|||||||||||||||||||
|
Current assets
|
|||||||||||||||||||
|
Cash and cash equivalents
|
$
|
—
|
|
$
|
0.6
|
|
$
|
529.3
|
|
$
|
—
|
|
$
|
529.9
|
|
||||
|
Trade receivables, net
|
—
|
|
43.0
|
|
140.1
|
|
—
|
|
183.1
|
|
|||||||||
|
Inventories
|
—
|
|
210.5
|
|
138.8
|
|
—
|
|
349.3
|
|
|||||||||
|
Other current assets
|
—
|
|
43.0
|
|
75.3
|
|
—
|
|
118.3
|
|
|||||||||
|
Total current assets
|
—
|
|
297.1
|
|
883.5
|
|
—
|
|
1,180.6
|
|
|||||||||
|
Investment in subsidiaries
|
3,657.7
|
|
1,385.7
|
|
—
|
|
(5,043.4
|
)
|
—
|
|
|||||||||
|
Intercompany receivables, net
(1)
|
—
|
|
849.5
|
|
51.2
|
|
(900.7
|
)
|
—
|
|
|||||||||
|
Property, plant and equipment, net
|
—
|
|
326.5
|
|
115.4
|
|
—
|
|
441.9
|
|
|||||||||
|
Goodwill
|
—
|
|
1,061.9
|
|
385.9
|
|
—
|
|
1,447.8
|
|
|||||||||
|
Other intangible assets, net
|
—
|
|
896.4
|
|
172.2
|
|
—
|
|
1,068.6
|
|
|||||||||
|
Other assets
|
1.4
|
|
0.1
|
|
32.1
|
|
—
|
|
33.6
|
|
|||||||||
|
Total assets
|
$
|
3,659.1
|
|
$
|
4,817.2
|
|
$
|
1,640.3
|
|
$
|
(5,944.1
|
)
|
$
|
4,172.5
|
|
||||
|
Liabilities and Shareholders' Equity
|
|||||||||||||||||||
|
Current liabilities
|
$
|
6.4
|
|
$
|
234.2
|
|
$
|
204.8
|
|
$
|
—
|
|
$
|
445.4
|
|
||||
|
Intercompany payables, net
(1)
|
900.7
|
|
—
|
|
—
|
|
(900.7
|
)
|
—
|
|
|||||||||
|
Long-term debt
|
1,095.7
|
|
583.0
|
|
—
|
|
—
|
|
1,678.7
|
|
|||||||||
|
Deferred income tax liabilities
|
—
|
|
109.3
|
|
34.6
|
|
—
|
|
143.9
|
|
|||||||||
|
Other liabilities
|
0.5
|
|
233.0
|
|
15.2
|
|
—
|
|
248.7
|
|
|||||||||
|
Total liabilities
|
2,003.3
|
|
1,159.5
|
|
254.6
|
|
(900.7
|
)
|
2,516.7
|
|
|||||||||
|
Total shareholders' equity
|
1,655.8
|
|
3,657.7
|
|
1,385.7
|
|
(5,043.4
|
)
|
1,655.8
|
|
|||||||||
|
Total liabilities and shareholders' equity
|
$
|
3,659.1
|
|
$
|
4,817.2
|
|
$
|
1,640.3
|
|
$
|
(5,944.1
|
)
|
$
|
4,172.5
|
|
||||
|
(1)
|
Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.
|
22
EDGEWELL PERSONAL CARE COMPANY
CONDENSED CONSOLIDATING BALANCE SHEETS
September 30, 2017
|
Parent Company
|
Guarantors
|
Non-Guarantors
|
Eliminations
|
Total
|
|||||||||||||||
|
Assets
|
|||||||||||||||||||
|
Current assets
|
|||||||||||||||||||
|
Cash and cash equivalents
|
$
|
—
|
|
$
|
6.4
|
|
$
|
496.5
|
|
$
|
—
|
|
$
|
502.9
|
|
||||
|
Trade receivables, net
|
—
|
|
34.4
|
|
189.7
|
|
—
|
|
224.1
|
|
|||||||||
|
Inventories
|
—
|
|
198.7
|
|
134.8
|
|
—
|
|
333.5
|
|
|||||||||
|
Other current assets
|
—
|
|
46.3
|
|
79.4
|
|
—
|
|
125.7
|
|
|||||||||
|
Total current assets
|
—
|
|
285.8
|
|
900.4
|
|
—
|
|
1,186.2
|
|
|||||||||
|
Investment in subsidiaries
|
3,554.1
|
|
1,363.2
|
|
—
|
|
(4,917.3
|
)
|
—
|
|
|||||||||
|
Intercompany receivables, net
(1)
|
—
|
|
644.2
|
|
54.7
|
|
(698.9
|
)
|
—
|
|
|||||||||
|
Property, plant and equipment, net
|
—
|
|
335.7
|
|
117.7
|
|
—
|
|
453.4
|
|
|||||||||
|
Goodwill
|
—
|
|
1,061.9
|
|
384.0
|
|
—
|
|
1,445.9
|
|
|||||||||
|
Other intangible assets, net
|
—
|
|
900.3
|
|
171.4
|
|
—
|
|
1,071.7
|
|
|||||||||
|
Other assets
|
1.6
|
|
0.1
|
|
29.9
|
|
—
|
|
31.6
|
|
|||||||||
|
Total assets
|
$
|
3,555.7
|
|
$
|
4,591.2
|
|
$
|
1,658.1
|
|
$
|
(5,616.2
|
)
|
$
|
4,188.8
|
|
||||
|
Liabilities and Shareholders' Equity
|
|||||||||||||||||||
|
Current liabilities
|
$
|
19.3
|
|
$
|
259.8
|
|
$
|
245.3
|
|
$
|
—
|
|
$
|
524.4
|
|
||||
|
Intercompany payables, net
(1)
|
698.9
|
|
—
|
|
—
|
|
(698.9
|
)
|
—
|
|
|||||||||
|
Long-term debt
|
1,095.4
|
|
430.0
|
|
—
|
|
—
|
|
1,525.4
|
|
|||||||||
|
Deferred income tax liabilities
|
—
|
|
147.6
|
|
34.2
|
|
—
|
|
181.8
|
|
|||||||||
|
Other liabilities
|
0.4
|
|
199.7
|
|
15.4
|
|
—
|
|
215.5
|
|
|||||||||
|
Total liabilities
|
1,814.0
|
|
1,037.1
|
|
294.9
|
|
(698.9
|
)
|
2,447.1
|
|
|||||||||
|
Total shareholders' equity
|
1,741.7
|
|
3,554.1
|
|
1,363.2
|
|
(4,917.3
|
)
|
1,741.7
|
|
|||||||||
|
Total liabilities and shareholders' equity
|
$
|
3,555.7
|
|
$
|
4,591.2
|
|
$
|
1,658.1
|
|
$
|
(5,616.2
|
)
|
$
|
4,188.8
|
|
||||
|
(1)
|
Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.
|
23
EDGEWELL PERSONAL CARE COMPANY
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
Three Months Ended December 31, 2017
|
Parent Company
|
Guarantors
|
Non-Guarantors
|
Eliminations
|
Total
|
|||||||||||||||
|
Net cash flow from (used by) operations
|
$
|
117.2
|
|
$
|
(168.2
|
)
|
$
|
30.0
|
|
$
|
—
|
|
$
|
(21.0
|
)
|
||||
|
Cash Flow from Investing Activities
|
|||||||||||||||||||
|
Capital expenditures
|
—
|
|
(9.2
|
)
|
(2.4
|
)
|
—
|
|
(11.6
|
)
|
|||||||||
|
Playtex gloves sale
|
—
|
|
19.0
|
|
—
|
|
—
|
|
19.0
|
|
|||||||||
|
Proceeds from sale of assets
|
—
|
|
2.1
|
|
—
|
|
—
|
|
2.1
|
|
|||||||||
|
Net cash from (used by) investing activities
|
—
|
|
11.9
|
|
(2.4
|
)
|
—
|
|
9.5
|
|
|||||||||
|
Cash Flow from Financing Activities
|
|||||||||||||||||||
|
Cash proceeds from debt with original maturities greater than 90 days
|
—
|
|
253.0
|
|
—
|
|
—
|
|
253.0
|
|
|||||||||
|
Cash payments on debt with original maturities greater than 90 days
|
—
|
|
(100.0
|
)
|
—
|
|
—
|
|
(100.0
|
)
|
|||||||||
|
Net (decrease) increase in debt with original maturities of 90 days or less
|
—
|
|
(2.5
|
)
|
1.2
|
|
—
|
|
(1.3
|
)
|
|||||||||
|
Common shares purchased
|
(115.2
|
)
|
—
|
|
—
|
|
—
|
|
(115.2
|
)
|
|||||||||
|
Employee shares withheld for taxes
|
(2.0
|
)
|
—
|
|
—
|
|
—
|
|
(2.0
|
)
|
|||||||||
|
Net cash (used by) from financing activities
|
(117.2
|
)
|
150.5
|
|
1.2
|
|
—
|
|
34.5
|
|
|||||||||
|
Effect of exchange rate changes on cash
|
—
|
|
—
|
|
4.0
|
|
—
|
|
4.0
|
|
|||||||||
|
Net (decrease) increase in cash and cash equivalents
|
—
|
|
(5.8
|
)
|
32.8
|
|
—
|
|
27.0
|
|
|||||||||
|
Cash and cash equivalents, beginning of period
|
—
|
|
6.4
|
|
496.5
|
|
—
|
|
502.9
|
|
|||||||||
|
Cash and cash equivalents, end of period
|
$
|
—
|
|
$
|
0.6
|
|
$
|
529.3
|
|
$
|
—
|
|
$
|
529.9
|
|
||||
24
EDGEWELL PERSONAL CARE COMPANY
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
Three Months Ended December 31, 2016
|
Parent Company
|
Guarantors
|
Non-Guarantors
|
Eliminations
|
Total
|
|||||||||||||||
|
Net cash flow from (used by) operations
|
$
|
65.1
|
|
$
|
(124.8
|
)
|
$
|
7.8
|
|
$
|
—
|
|
$
|
(51.9
|
)
|
||||
|
Cash Flow from Investing Activities
|
|||||||||||||||||||
|
Capital expenditures
|
—
|
|
(11.0
|
)
|
(2.7
|
)
|
—
|
|
(13.7
|
)
|
|||||||||
|
Acquisitions, net of cash acquired
|
—
|
|
—
|
|
(34.0
|
)
|
—
|
|
(34.0
|
)
|
|||||||||
|
Net cash used by investing activities
|
—
|
|
(11.0
|
)
|
(36.7
|
)
|
—
|
|
(47.7
|
)
|
|||||||||
|
Cash Flow from Financing Activities
|
|||||||||||||||||||
|
Cash proceeds from debt with original maturities greater than 90 days
|
—
|
|
146.0
|
|
—
|
|
—
|
|
146.0
|
|
|||||||||
|
Cash payments on debt with original maturities greater than 90 days
|
—
|
|
(10.0
|
)
|
(277.0
|
)
|
—
|
|
(287.0
|
)
|
|||||||||
|
Net (decrease) increase in debt with original maturities of 90 days or less
|
—
|
|
(0.9
|
)
|
0.5
|
|
—
|
|
(0.4
|
)
|
|||||||||
|
Common shares purchased
|
(58.0
|
)
|
—
|
|
—
|
|
—
|
|
(58.0
|
)
|
|||||||||
|
Employee shares withheld for taxes
|
(7.1
|
)
|
—
|
|
—
|
|
—
|
|
(7.1
|
)
|
|||||||||
|
Net cash (used by) from financing activities
|
(65.1
|
)
|
135.1
|
|
(276.5
|
)
|
—
|
|
(206.5
|
)
|
|||||||||
|
Effect of exchange rate changes on cash
|
—
|
|
—
|
|
(14.3
|
)
|
—
|
|
(14.3
|
)
|
|||||||||
|
Net decrease in cash and cash equivalents
|
—
|
|
(0.7
|
)
|
(319.7
|
)
|
—
|
|
(320.4
|
)
|
|||||||||
|
Cash and cash equivalents, beginning of period
|
—
|
|
5.8
|
|
733.1
|
|
—
|
|
738.9
|
|
|||||||||
|
Cash and cash equivalents, end of period
|
$
|
—
|
|
$
|
5.1
|
|
$
|
413.4
|
|
$
|
—
|
|
$
|
418.5
|
|
||||
25
On January 15, 2018, the Company entered into an agreement to acquire Jack Black, L.L.C. ("Jack Black"), a leading U.S. based luxury men's skincare products company based in Dallas, Texas. The acquisition, which is expected to close in the second quarter of fiscal 2018, will create opportunities to expand Edgewell's personal care portfolio in growing categories in the U.S. and globally, while nurturing the brand equity of Jack Black. The transaction will be funded from operating cash.
(in millions, except per share data, unaudited)
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and the accompanying notes included in this Quarterly Report on Form 10-Q, and our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on November 20, 2017. The following discussion may contain forward-looking statements that reflect our plans, estimates and beliefs and involve risks, uncertainties and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed within "Forward-Looking Statements" below, and in Item 1A. Risk Factors and "Forward-Looking Statements" included within our Annual Report on Form 10-K.
Non-GAAP Financial Measures.
While we report financial results in accordance with accounting principles generally accepted in the United States ("reported" or "GAAP"), this discussion also includes Non-GAAP measures. These Non-GAAP measures are referred to as "adjusted" or "organic" and exclude items such as the disposition of Playtex gloves business, the impact of the Tax Cuts and Jobs Act (the "Tax Act"), the acquisition of Bulldog Skincare Holdings Limited ("Bulldog"), restructuring charges and amortization of intangibles. Reconciliations of Non-GAAP measures are included within this Management's Discussion and Analysis of Financial Condition and Results of Operations.
This Non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this Non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This Non-GAAP information is a component in determining management's incentive compensation. Finally, we believe this information provides a higher degree of transparency. The following provides additional detail on our Non-GAAP measures:
|
•
|
We analyze our net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency, acquisitions and dispositions (including the disposition of the gloves business and acquisition of Bulldog). This information is provided because these types of fluctuations can distort the underlying change in net sales and segment profit either positively or negatively.
|
|
•
|
Adjusted net earnings and adjusted earnings per share are defined as net earnings and diluted earnings per share excluding items such as the gain on the disposition of the gloves business, restructuring charges, the related tax effects of these items and the impact of the Tax Act.
|
|
•
|
Adjusted effective tax rate is defined as the effective tax rate excluding items such as the gain on the disposition of the gloves business, restructuring charges, the related tax effects of these items and the impact of the Tax Act from the income tax provision and earnings before income taxes.
|
All comparisons are with the same period in the prior year, unless otherwise noted.
Industry and Market Data.
Unless we indicate otherwise, we base the information concerning our industry contained or incorporated by reference herein on our general knowledge of and expectations concerning the industry. Our market position, market share and industry market size is based on our estimates using internal data and data from various industry analyses, our internal research and adjustments and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses and cannot guarantee accuracy or completeness. In addition, we believe that data regarding the industry, market size and our market position and market share within such industry provide general guidance but are inherently imprecise. Further, our estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those discussed in the "Risk Factors" section of our Annual Report on Form 10-K. These and other factors could cause results to differ materially from those expressed in the estimates and assumptions.
26
Retail sales for purposes of market size, market position and market share information are based on retail sales in United States ("U.S.") dollars.
Trademarks and Trade Names.
We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which appear throughout this Quarterly Report on Form 10-Q. We also may refer to brand names, trademarks, service marks and trade names of other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their respective owners.
Forward-Looking Statements.
This document contains both historical and forward-looking statements. Forward-looking statements are not based on historical facts, but instead reflect our expectations, estimates or projections concerning future results or events, including, without limitation, the future earnings and performance of Edgewell Personal Care Company or any of our businesses. These statements generally can be identified by the use of forward-looking words or phrases such as "believe," "expect," "expectation," "anticipate," "may," "could," "intend," "belief," "estimate," "plan," "target," "predict," "likely," "will," "should," "forecast," "outlook," or other similar words or phrases. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this document are only made as of the date of this document, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances. Numerous factors could cause our actual results and events to differ materially from those expressed or implied by forward-looking statements, including, without limitation:
|
•
|
We face risks associated with global economic conditions.
|
|
•
|
Competition in our industries may hinder our ability to execute our business strategy, achieve profitability, or maintain relationships with existing customers.
|
|
•
|
Loss of any of our principal customers could significantly decrease our sales and profitability.
|
|
•
|
Our inability to execute a successful e-commerce strategy could have a significant impact on our business.
|
|
•
|
Changes in production costs, including raw material prices, could erode our profit margins and negatively impact operating results.
|
|
•
|
Loss of reputation of our leading brands or failure of our marketing plans could have an adverse effect on our business.
|
|
•
|
We are subject to risks related to our international operations, including currency fluctuations, which could adversely affect our results of operations.
|
|
•
|
We face risks arising from our ongoing efforts to achieve cost savings.
|
|
•
|
If we cannot continue to develop new products in a timely manner, and at favorable margins, we may not be able to compete effectively.
|
|
•
|
We may not be able to continue to identify and complete strategic acquisitions and effectively integrate acquired companies to achieve desired financial benefits.
|
|
•
|
A failure of a key information technology system or a breach of our information security could adversely impact our ability to conduct business.
|
|
•
|
Our business is subject to increasing global regulation, including product related regulations and environmental regulations, that may expose us to significant liabilities.
|
|
•
|
Our access to capital markets and borrowing capacity could be limited.
|
|
•
|
Impairment of our goodwill and other intangible assets would result in a reduction in net income.
|
|
•
|
Legislative changes in applicable tax laws, policies and regulations or unfavorable resolution of tax matters may result in additional tax liabilities, which could adversely impact our cash flows and results of operations.
|
|
•
|
Our manufacturing facilities, supply channels or other business operations may be subject to disruption from events beyond our control.
|
|
•
|
We have a substantial level of indebtedness and are subject to various covenants relating to such indebtedness, which could limit our discretion to operate and grow our business.
|
|
•
|
Our business is subject to seasonal volatility.
|
|
•
|
There can be no guarantee that we will repurchase stock.
|
|
•
|
We do not expect to pay dividends for the foreseeable future.
|
|
•
|
If we fail to adequately protect our intellectual property rights, competitors may manufacture and market similar products, which could adversely affect our market share and results of operations.
|
27
|
•
|
Our financial results could be adversely impacted by the United Kingdom's departure from the European Union.
|
|
•
|
Our business involves the potential for product liability and other claims against us, which could affect our results of operations and financial condition and result in product recalls or withdrawals.
|
|
•
|
Our business could be negatively impacted as a result of stockholder activism or an unsolicited takeover proposal or a proxy contest.
|
|
•
|
We may not be able to attract, retain and develop key personnel.
|
|
•
|
We may experience losses or be subject to increased funding and expenses related to our pension plans.
|
|
•
|
Certain provisions in our articles of incorporation and bylaws, and of Missouri law, could deter or delay a third-party's effort to acquire us, especially if the Board determines it is not in the best interest of our shareholders.
|
|
•
|
The trading price of our common shares may be volatile.
|
|
•
|
Our historical financial information is not necessarily representative of the results that we would have achieved had the Separation taken place before July 1, 2015, and may not be a reliable indicator of our future results.
|
|
•
|
If the Separation, together with certain related transactions, does not qualify as a transaction that is generally tax free for U.S. federal income tax purposes, our shareholders could be subject to significant tax liabilities.
|
|
•
|
Indemnifications under the Separation agreement with New Energizer or New Energizer’s inability to satisfy indemnification obligations in the future could negatively impact our financial results.
|
In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly affect the accuracy of any such forward-looking statements. The list of factors above is illustrative, but not exhaustive. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Additional risks and uncertainties include those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of our Annual Report on Form 10-K.
Overview
Edgewell Personal Care Company, and its subsidiaries (collectively, "Edgewell"), is one of the world's largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. We have a portfolio of over
25
brands and a broad global footprint that operates in more than
50
countries.
We conduct our business in the following four segments:
|
•
|
Wet Shave
consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. Our wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams.
|
|
•
|
Sun and Skin Care
consists of Banana Boat® and Hawaiian Tropic® sun care products, Bulldog® men's skin care products, Wet Ones® wipes and Playtex® household gloves until the sale of the gloves business in October 2017. Refer to Note 2 for additional details on the sale of the Playtex household gloves business.
|
|
•
|
Feminine Care
includes tampons, pads and liners sold under the Playtex® Gentle Glide® and Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand.
|
|
•
|
All Other
includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems.
|
The personal care product categories are highly competitive, both in the U.S. and on a global basis, as large manufacturers with global operations compete for consumer acceptance and, increasingly, limited retail shelf space. Competition is based upon brand perception, product performance, customer service and price. The markets are generally characterized by the frequent introduction of new products, accompanied by major advertising and promotional programs. Our priority is to deliver our strategic objectives, focusing on maximizing sales and profit growth through innovation, product line extensions and share gains, as well as improving working capital management.
28
Significant Events
Sale of Playtex Gloves Business
On October 26, 2017, the Company finalized its sale of the Playtex® gloves business to a household products company (the “Acquirer”) for
$19.0
. The sale was finalized on October 26, 2017. The sale provides the Acquirer with indefinite and exclusive worldwide rights to the Playtex trademark for gloves. The strategic sale of the Playtex gloves business will allow the Company to better focus and utilize its resources on its other product lines. Total assets sold were
$3.1
, resulting in a pre-tax gain on sale of
$15.9
.
Acquisition of Bulldog
On October 31, 2016, we completed the acquisition of Bulldog, a men's grooming and skincare products company based in the United Kingdom (the "U.K.") for
$34.0
, net of cash acquired. The acquisition created opportunities to expand our personal care portfolio into a growing global category where we can leverage our international geographic footprint. The acquisition was financed through available foreign cash. The results of Bulldog for the post-acquisition period are included within our results for the first quarter of fiscal 2018 and 2017.
Changes in Executive Management Team
On December 12, 2017, we announced the departure of Sandy Sheldon, Chief Financial Officer. We have begun the process to identify and select a permanent CFO, and have retained a nationally recognized executive search firm to facilitate the process.
Executive Summary
Following is a summary of key results for the
first quarter
of fiscal 2018 as compared to the first quarter of fiscal 2017. Net earnings and earnings per share ("EPS") for the time periods presented were impacted by the gain on the sale of the Playtex gloves business, restructuring activities, the related tax impact from those costs and the impact of the Tax Act as described in the table below. The impact of these items on reported net earnings and EPS are provided as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, which are Non-GAAP measures.
First Quarter of Fiscal 2018
|
•
|
Net sales
in the
first quarter
of fiscal 2018 were
$468.3
, down
3.4%
compared to the prior year quarter, inclusive of a
0.5%
increase as a result of the acquisition of Bulldog, a
0.7%
decline from the sale of the Playtex gloves business and a
2.0%
increase due to currency movements. Excluding the impact of the Bulldog acquisition, the sale of the Playtex gloves business and currency movements, organic net sales
decreased
5.2%
as declines in Wet Shave and Feminine Care were partially offset by growth in Sun and Skin Care.
|
|
•
|
Net earnings
in the
first quarter
of fiscal 2018 were
$6.7
as compared to
$33.5
in the prior year. On an adjusted basis, as illustrated in the following table, net earnings for the
first quarter
of fiscal 2018
decreased
70.6%
to
$11.3
. The decline was primarily driven by decreased net sales and lower gross margin.
|
|
•
|
Net earnings per diluted share
during the
first quarter
of fiscal 2018 was
$0.12
compared to
$0.58
in the prior year period. On an adjusted basis, as illustrated in the following table, net earnings per diluted share during the
first quarter
of fiscal 2018 was
$0.20
compared to
$0.66
in the prior year.
|
29
|
Quarter Ended December 31,
|
|||||||||||||||
|
Net Earnings
|
Diluted EPS
|
||||||||||||||
|
2017
|
2016
|
2017
|
2016
|
||||||||||||
|
Net Earnings and Diluted EPS - GAAP
|
$
|
6.7
|
|
$
|
33.5
|
|
$
|
0.12
|
|
$
|
0.58
|
|
|||
|
Gain on sale of Playtex gloves
|
(15.9
|
)
|
—
|
|
(0.29
|
)
|
—
|
|
|||||||
|
Restructuring and related costs
(1)
|
—
|
|
7.2
|
|
—
|
|
0.12
|
|
|||||||
|
Income taxes
(2)
|
20.5
|
|
(2.3
|
)
|
0.37
|
|
(0.04
|
)
|
|||||||
|
Adjusted Net Earnings and Adjusted Diluted EPS - Non-GAAP
|
$
|
11.3
|
|
$
|
38.4
|
|
$
|
0.20
|
|
$
|
0.66
|
|
|||
|
Weighted-average shares outstanding - Diluted
|
55.6
|
|
58.1
|
|
|||||||||||
|
(1)
|
Includes pre-tax Cost of products sold of
$0.3
for the first quarter of fiscal 2017 associated with obsolescence charges related to the exit of certain non-core product lines as part of the Restructuring.
|
|
(2)
|
Includes the impact of the Tax Act totaling $16.2 in Income tax expense for the first quarter of fiscal 2018 in addition to the tax impact of the other adjustments to Net Earnings and Diluted EPS - GAAP.
|
Operating Results
The following table presents changes in net sales for the
first quarter
of fiscal 2018, as compared to the corresponding period in fiscal 2017, and provides a reconciliation of organic net sales to reported amounts.
Net Sales
|
Net Sales - Total Company
|
||||||
|
Quarter Ended December 31, 2017
|
||||||
|
Q1
|
% Chg
|
|||||
|
Net sales - prior year
|
$
|
485.0
|
|
|||
|
Organic
|
(25.0
|
)
|
(5.2
|
)%
|
||
|
Impact of Playtex gloves sale
|
(3.2
|
)
|
(0.7
|
)%
|
||
|
Impact of Bulldog acquisition
|
2.3
|
|
0.5
|
%
|
||
|
Impact of currency
|
9.2
|
|
2.0
|
%
|
||
|
Net sales - current year
|
$
|
468.3
|
|
(3.4
|
)%
|
|
For the
first quarter
of fiscal 2018, net sales were
$468.3
, a
3.4%
decrease
when compared with the prior year period. Excluding the impact of the acquisition of Bulldog, the sale of the Playtex gloves business and currency movements, organic net sales
decreased
5.2%
versus the prior year period, as overall volumes decreased primarily in North America Wet Shave and Feminine Care. Wet Shave was impacted by unfavorable price mix in the quarter. Sun and Skin Care organic net sales grew
2.6%
in the quarter while organic net sales in All Other was flat.
We expect net sales for the full year to be flat to up 1% compared to the prior year, including a currency benefit of approximately 2%, that is partially offset by a 0.5% decline from the Playtex gloves divestiture, net of acquisitions. Organic net sales for the year are expected to decrease approximately 1%. Wet Shave organic net sales are expected to be relatively flat assuming continued category declines and softening international category trends. Innovation launches by the Company across the Wet Shave segment are expected to grow share in this decelerating environment in addition to expected gains in e-commerce distribution and share. In Sun and Skin Care, organic net sales are expected to grow in the mid to low single digits through product innovation, market expansion and distribution gains, including organic growth in Bulldog. In Feminine Care, sales declines are expected to continue for the majority of fiscal 2018 as a result of distribution losses and competitive pressures.
For further discussion regarding net sales, including a summary of reported versus organic changes, see "Segment Results."
Gross Profit
Gross profit was
$200.3
during the
first quarter
of fiscal 2018, as compared to
$228.0
in the prior year period. Gross margin as a percent of net sales for the
first quarter
of fiscal 2018 was
42.8%
, representing a
420
basis point decline over the prior year
30
gross margin of
47.0%
. The gross profit decline was driven by lower sales volumes and unfavorable product mix, higher promotional activity in Wet Shave and Sun and Skin Care, and increased product costs. Higher product costs were primarily driven by lower production volumes in both Feminine Care and Sun and Skin Care manufacturing compared to the prior year, increased costs related to Wet Shave footprint changes, higher commodity costs, and an unfavorable impact from transactional currency.
Selling, General and Administrative Expense
Selling, general and administrative expense was
$97.2
in the
first quarter
of fiscal 2018, or
20.8%
of net sales, as compared to
$93.8
in the prior year period, or
19.3%
of net sales. The increase in expenses relates to investments in e-commerce, executive severance, and expense related to one of our Zero Based Spending ("ZBS') initiatives that will yield savings going forward. Amortization expense also increased from the conversion of the Playtex and Edge brand names to definite lived intangible assets in the fourth quarter of fiscal 2017.
Advertising and Sales Promotion Expense
For the
first quarter
of fiscal 2018, advertising and promotion expense ("A&P ") was
$49.0
,
down
$1.6
as compared to the prior year period. A&P spending as a percent of net sales was
10.5%
, as compared to
10.4%
in the prior year period.
Research and Development Expense
Research and development ("R&D") for the
first quarter
of fiscal 2018 was
$16.1
, compared to
$16.3
in the prior year period. As a percent of sales, R&D was consistent at
3.4%
in both the current quarter and the prior year period.
Interest Expense Associated with Debt
Interest expense associated with debt for the
first quarter
of fiscal 2018 was
$17.8
, an increase from the prior year period of
$17.4
. The increase in interest expense was the result of higher average debt outstanding under the U.S. credit facility driven by borrowings to finance share repurchase activity in the current year.
Other (Income) Expense, Net
Other (income) expense, net was
$3.0
of expense in the first quarter of fiscal 2018 compared to
$1.9
of income in the prior year period, reflecting the impact of foreign currency exchange contract gains and losses and the revaluation of nonfunctional currency balance sheet exposures.
Income Tax Provision
The effective tax rate for the first quarters of fiscal 2018 and 2017 was
79.8%
and
25.4%
, respectively. The effective tax rate for the current period includes a $16.2 increase in tax expense related to net charges from the Tax Act. In addition the lower U.S. Federal tax rate was more than offset by unfavorable tax adjustments related to stock compensation and prior year provision estimates, yielding a combined increase of 5% to the effective tax rate. The effective tax rate for the first quarter of fiscal 2017 includes favorable adjustments related to prior year provision estimates, which reduced the effective rate by approximately 4%. Excluding the gain on sale of the Playtex gloves business, net tax expense from the Tax Act and costs related to restructuring charges, the adjusted effective tax rate was
34.1%
and
26.3%
for the first quarter of fiscal 2018 and 2017, respectively. The adjusted effective tax rate for fiscal 2018 is expected to be in the range of 22% to 24%; however, both the effective tax rate and the adjusted effective tax rate are dependent upon the mix of earnings in various tax jurisdictions.
31
The following table presents a reconciliation of the adjusted effective tax rate, which is a Non-GAAP measure:
|
Three Months Ended December 31, 2017
|
Three Months Ended December 31, 2016
|
||||||||||||||||||||||
|
Reported
|
Adjustments
(1)
|
Adjusted
(Non-GAAP)
|
Reported
|
Adjustments
(1)
|
Adjusted
(Non-GAAP)
|
||||||||||||||||||
|
Earnings before income taxes
|
$
|
33.1
|
|
$
|
(15.9
|
)
|
$
|
17.2
|
|
$
|
44.9
|
|
$
|
7.2
|
|
$
|
52.1
|
|
|||||
|
Income tax provision
|
26.4
|
|
(20.5
|
)
|
5.9
|
|
11.4
|
|
2.3
|
|
13.7
|
|
|||||||||||
|
Net earnings
|
$
|
6.7
|
|
$
|
4.6
|
|
$
|
11.3
|
|
$
|
33.5
|
|
$
|
4.9
|
|
$
|
38.4
|
|
|||||
|
Effective tax rate
|
79.8
|
%
|
25.4
|
%
|
|||||||||||||||||||
|
Adjusted effective tax rate
|
34.1
|
%
|
26.3
|
%
|
|||||||||||||||||||
|
(1)
|
Includes adjustments for the impact of the Tax Act, the gain on sale of the Playtex gloves business, and restructuring charges. See reconciliation of net earnings to adjusted net earnings.
|
Savings Initiatives
Our ZBS initiative was established to capture savings and establish cost-conscious spending policies consistent with our strategic needs. Net cost savings from our ZBS initiative is anticipated to be between $25 to $30 in fiscal 2018, which will principally fund investments in core and growth initiatives and increased marketing spend. In addition, we have launched an expansion of our ZBS initiative to assess our organizational and operational cost structure in order to continue to drive incremental savings and accelerate shift to growth opportunities.
Segment Results
Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, costs associated with restructuring initiatives and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance.
Our operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, a combined sales force and management teams. We apply a fully allocated cost basis, in which shared business functions are allocated between the segments. Such allocations are estimates, and do not represent the costs of such services if performed on a stand-alone basis.
The following tables present changes in segment net sales and segment profit for the
first quarter
of fiscal 2018, as compared to the corresponding period in fiscal 2017, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings before income taxes, see Note 15 of Notes to Condensed Consolidated Financial Statements.
Wet Shave
|
Net Sales - Wet Shave
|
||||||
|
Quarter Ended December 31, 2017
|
||||||
|
Q1
|
% Chg
|
|||||
|
Net sales - prior year
|
$
|
306.2
|
|
|||
|
Organic
|
(19.7
|
)
|
(6.4
|
)%
|
||
|
Impact of currency
|
7.6
|
|
2.4
|
%
|
||
|
Net sales - current year
|
$
|
294.1
|
|
(4.0
|
)%
|
|
Wet Shave net sales for the
first quarter
of fiscal 2018
decreased
4.0%
, inclusive of a
2.4%
increase
due to currency movements. Excluding the impact of currency movements, organic net sales decreased
$19.7
, or
6.4%
, as a result of lower volumes. The volume decline in North America Men's systems reflects the impact of distribution losses in the current quarter, compared to strong performance a year ago, when Men's systems organic net sales grew 28%. Women's systems were essentially flat globally, but delivered 2% growth in North America. International Wet Shave organic net sales declined 2% in the quarter, driven by lower volumes in Europe and unfavorable price mix in Asia.
32
|
Segment Profit - Wet Shave
|
||||||
|
Quarter Ended December 31, 2017
|
||||||
|
Q1
|
% Chg
|
|||||
|
Segment profit - prior year
|
$
|
72.0
|
|
|||
|
Organic
|
(19.0
|
)
|
(26.4
|
)%
|
||
|
Impact of currency
|
1.7
|
|
2.4
|
%
|
||
|
Segment profit - current year
|
$
|
54.7
|
|
(24.0
|
)%
|
|
Wet Shave segment profit for the
first quarter
of fiscal 2018 was
$54.7
,
down
$17.3
or
24.0%
, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit
decreased
$19.0
, or
26.4%
, driven by lower volumes, unfavorable product mix, higher promotional spending, costs associated with manufacturing footprint efforts, higher commodity costs, and unfavorable transactional currency.
Sun and Skin Care
Sun and Skin Care segment net sales and segment profit are affected by the seasonality of sun care products. As a result, segment net sales and segment profit tend to be higher in the second and third quarters of the fiscal year.
|
Net Sales - Sun and Skin Care
|
||||||
|
Quarter Ended December 31, 2017
|
||||||
|
Q1
|
% Chg
|
|||||
|
Net sales - prior year
|
$
|
57.6
|
|
|||
|
Organic
|
1.5
|
|
2.6
|
%
|
||
|
Impact of Playtex gloves disposition
|
(3.2
|
)
|
(5.6
|
)%
|
||
|
Impact of Bulldog acquisition
|
2.3
|
|
4.0
|
%
|
||
|
Impact of currency
|
0.9
|
|
1.6
|
%
|
||
|
Net sales - current year
|
$
|
59.1
|
|
2.6
|
%
|
|
Sun and Skin Care net sales for the
first quarter
of fiscal 2018
increased
2.6%
, inclusive of a
4.0%
increase due to the acquisition of Bulldog and a
1.6%
increase
due to currency movements, offset by a
5.6%
decline from the disposition of the Playtex gloves business. Excluding the impact of the Bulldog acquisition, sale of the Playtex gloves business and currency movements, organic net sales
increased
$1.5
, or
2.6%
, driven by growth in North America of nearly 7% from increased volumes from Banana Boat and Bulldog, offset by higher promotional spending. International organic net sales decreased 2%, primarily driven by volume declines and increased promotional spending in Asia.
|
Segment Profit - Sun and Skin Care
|
||||||
|
Quarter Ended December 31, 2017
|
||||||
|
Q1
|
% Chg
|
|||||
|
Segment profit - prior year
|
$
|
0.8
|
|
|||
|
Organic
|
(4.6
|
)
|
(575.0
|
)%
|
||
|
Impact of Playtex gloves disposition
|
(1.0
|
)
|
(125.0
|
)%
|
||
|
Impact of Bulldog acquisition
|
(1.3
|
)
|
(162.5
|
)%
|
||
|
Impact of currency
|
—
|
|
—
|
%
|
||
|
Segment loss - current year
|
$
|
(6.1
|
)
|
(862.5
|
)%
|
|
Segment loss for the
first quarter
of fiscal 2018 was
$6.1
,
a decrease
of
$6.9
or
862.5%
, inclusive of the impact of the acquisition of Bulldog, sale of the Playtex gloves business and currency movements. Excluding the impact of the Bulldog acquisition and the disposition of the Playtex gloves business, organic segment profit
decreased
$4.6
, or
575.0%
, driven by increased promotional support to close the sun care season and higher product costs in the current year compared to a year ago, when production volumes were high as aerosol production was first insourced at our Ormond Beach plant.
33
Feminine Care
|
Net Sales - Feminine Care
|
||||||
|
Quarter Ended December 31, 2017
|
||||||
|
Q1
|
% Chg
|
|||||
|
Net sales - prior year
|
$
|
89.1
|
|
|||
|
Organic
|
(6.8
|
)
|
(7.6
|
)%
|
||
|
Impact of currency
|
0.3
|
|
0.3
|
%
|
||
|
Net sales - current year
|
$
|
82.6
|
|
(7.3
|
)%
|
|
Feminine Care net sales for the
first quarter
of fiscal 2018
decreased
$6.5
, or
7.3%
, inclusive of a
0.3%
increase
due to the impact of currency movements. Excluding the impact of currency movements, organic net sales
decreased
7.6%
, due to volume declines in tampons and pads related to prior distribution losses, offset in part by growth in Carefree liners.
|
Segment Profit - Feminine Care
|
||||||
|
Quarter Ended December 31, 2017
|
||||||
|
Q1
|
%Chg
|
|||||
|
Segment profit - prior year
|
$
|
8.3
|
|
|||
|
Organic
|
(3.5
|
)
|
(42.2
|
)%
|
||
|
Impact of currency
|
0.2
|
|
2.4
|
%
|
||
|
Segment profit - current year
|
$
|
5.0
|
|
(39.8
|
)%
|
|
Feminine Care segment profit for the
first quarter
of fiscal 2018 was
$5.0
,
a decrease
of
$3.3
, or
39.8%
, inclusive of a
2.4%
increase
due to the impact of currency movements. Excluding the impact of currency movements, organic segment profit
decreased
$3.5
, or
42.2%
, due to lower volumes and higher product costs compared to the prior year, when production volumes were higher in advance of the final consolidation of manufacturing into one plant.
All Other
|
Net Sales - All Other
|
||||||
|
Quarter Ended December 31, 2017
|
||||||
|
Q1
|
%Chg
|
|||||
|
Net sales - prior year
|
$
|
32.1
|
|
|||
|
Organic
|
—
|
|
—
|
%
|
||
|
Impact of currency
|
0.4
|
|
1.2
|
%
|
||
|
Net sales - current year
|
$
|
32.5
|
|
1.2
|
%
|
|
All Other net sales for the
first quarter
of fiscal 2018
increased
1.2%
, due to a
1.2%
increase
from the impact of currency movements.
Excluding the impact of currency movements, organic net sales remained flat compared to the prior year quarter as growth in Diaper Genie and Pet Care was offset by declines in infant feeding products.
|
Segment Profit - All Other
|
||||||
|
Quarter Ended December 31, 2017
|
||||||
|
Q1
|
%Chg
|
|||||
|
Segment profit - prior year
|
$
|
6.9
|
|
|||
|
Organic
|
0.1
|
|
1.4
|
%
|
||
|
Impact of currency
|
0.2
|
|
2.9
|
%
|
||
|
Segment profit - current year
|
$
|
7.2
|
|
4.3
|
%
|
|
All Other segment profit for the
first quarter
of fiscal 2018 was
$7.2
,
an increase
of
$0.3
, or
4.3%
, inclusive of a
2.9%
increase
due to the impact of currency movements. Excluding the impact of currency movements, organic segment profit
increased
1.4%
.
34
General Corporate and Other Expenses
|
Quarter Ended December 31,
|
|||||||
|
2017
|
2016
|
||||||
|
Corporate expenses
|
$
|
18.4
|
|
$
|
16.4
|
|
|
|
Gain on sale of Playtex gloves
|
(15.9
|
)
|
—
|
|
|||
|
Restructuring and related costs
(1)
|
—
|
|
7.2
|
|
|||
|
General corporate and other expenses
|
$
|
2.5
|
|
$
|
23.6
|
|
|
|
% of net sales
|
0.5
|
%
|
4.9
|
%
|
|||
|
(1)
|
Includes pre-tax Cost of products sold of
$0.3
for the first quarter of fiscal 2017 associated with obsolescence charges related to the exit of certain non-core product lines as a part of the Restructuring.
|
For the
first quarter
of fiscal 2018, general corporate expenses were
$18.4
, or
3.9%
of net sales, as compared to
$16.4
, or
3.4%
of net sales, in the prior year quarter. The increase in corporate expenses compared to the prior year quarter was driven by a loss on the sale of an asset related to our ZBS initiative and executive severance related charges.
Liquidity and Capital Resources
At
December 31, 2017
, substantially all of our cash balances were located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-US subsidiaries only if the economic cost of the repatriation is not considered material. As a result of the Tax Act signed December 22, 2017, we expect to repatriate a significant amount of cash from foreign subsidiaries. We are currently evaluating the amount and expected uses of repatriated cash. We do not expect the incremental cost of repatriating cash to be material.
The counterparties to deposits consist of a number of major financial institutions. We consistently monitor positions with, and credit ratings of, counterparties both internally and by using outside ratings agencies.
Our total borrowings were
$1,699.8
at
December 31, 2017
, including
$603.8
tied to variable interest rates. Our total borrowings at
September 30, 2017
were
$1,544.8
. The increase in borrowings during the quarter were used to finance share repurchases.
As of
December 31, 2017
, we had outstanding borrowings of
$398.0
under our unsecured revolving credit facility in the U.S. (the "Revolving Facility") and
$8.0
of outstanding letters of credit. Taking into account outstanding borrowings and outstanding letters of credit at
December 31, 2017
,
$319.0
remains available under the Revolving Facility. At
September 30, 2017
, we had outstanding borrowings of
$245.0
under the Revolving Facility. As of December 31, 2017 and September 30, 2016, we had approximately $185.0 outstanding under a term loan.
We had outstanding international borrowings, recorded in Notes payable, of
$21.1
and
$19.4
as of
December 31, 2017
and
September 30, 2017
, respectively.
The expected minimum required contribution to our pension plans in fiscal 2018 is
$9.6
; however, discretionary contributions may also be made. During the first quarter of fiscal 2018, we contributed
$2.4
to our pension plans.
As of
December 31, 2017
, we were in compliance with the provisions and covenants associated with our debt agreements.
35
Cash Flows
A summary of our cash flow activities is provided in the following table:
|
Three Months Ended December 31,
|
|||||||
|
2017
|
2016
|
||||||
|
Net cash (used by) from:
|
|||||||
|
Operating activities
|
$
|
(21.0
|
)
|
$
|
(51.9
|
)
|
|
|
Investing activities
|
9.5
|
|
(47.7
|
)
|
|||
|
Financing activities
|
34.5
|
|
(206.5
|
)
|
|||
|
Effect of exchange rate changes on cash
|
4.0
|
|
(14.3
|
)
|
|||
|
Net increase (decrease) in cash and cash equivalents
|
$
|
27.0
|
|
$
|
(320.4
|
)
|
|
Operating Activities
Cash flow used by operating activities was
$21.0
during the first quarter of fiscal 2018, as compared to
$51.9
during the same period in the prior year. Due to the seasonality of the Company's business, primarily in Sun Care, the first fiscal quarter is typically the lowest operating cash flow quarter of the year. The improvement in operating cash flow was driven by changes in working capital, primarily accounts receivable and inventory. Changes in cash flows from Operating activities resulting from the Tax Act include a reduction in Net Earnings from the net transition charge of $16.2, a non-cash deferred tax adjustment and an offsetting change in operating assets and liabilities from the increase in current and long-term income taxes payable. The Company expects that fiscal 2018 free cash flow will be above 100% of GAAP net earnings.
Investing Activities
Cash flow from investing activities was
$9.5
during the first quarter of fiscal 2018 as compared to cash used by investing activities of
$47.7
during the same period in the prior year. The change was primarily due to the $34.0 acquisition of Bulldog in the first quarter of fiscal 2017 and the $19.0 sale of the Playtex gloves business in fiscal 2018. Capital expenditures were
$11.6
during the first quarter of fiscal 2018 compared to
$13.7
during the same period in the prior year.
Financing Activities
Net cash from financing activities was
$34.5
during the first quarter of fiscal 2018 as compared to net cash used by financing activities of
$206.5
during the same period in the prior year. During the first quarter of fiscal 2018, we had
$153.0
of additional borrowings under the Revolving Facility offset in part by share repurchases of
$115.2
. In the prior year period, the Company had net debt repayments of $141.0 under the Revolving Facility and share repurchases of $58.0.
Share Repurchases
During the first quarter of fiscal 2018, we repurchased
1.9
shares of our common stock for
$115.2
, all of which were purchased under the previous authorization from May 2015. In January 2018, the Board approved an authorization to repurchase up to
10.0
shares of the Company's common stock, replacing the previous stock repurchase authorization from May 2015. Any future share repurchases would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs and other factors.
Commitments and Contingencies
Contractual Obligations
During the first three months of fiscal 2018, our net borrowings on our revolving credit facilities were
$153.0
. As of
December 31, 2017
, future minimum repayments of debt are as follows:
$185.0
in fiscal 2019,
$398.0
in fiscal 2020,
$600.0
in fiscal 2021 and
$500.0
in fiscal 2022.
There have been no other material changes in our contractual obligations since the presentation in our Annual Report on Form 10-K, as filed with the SEC on November 20, 2017.
36
Environmental Matters
Our operations, like those of other companies, are subject to various federal, state, foreign and local laws and regulations intended to protect the public health and the environment. These regulations relate primarily to worker safety, air and water quality, underground fuel storage tanks and waste handling and disposal. It is difficult to quantify with certainty the cost of environmental matters, particularly remediation and future capital expenditures for environmental control equipment. Total environmental capital expenditures and operating expenses are not expected to have a material effect on our total capital and operating expenditures, consolidated earnings or competitive position. However, current environmental spending estimates could be modified as a result of changes in our plans or our understanding of underlying facts, changes in legal requirements, including any requirements related to global climate change, or other factors.
Legal and Other Contingencies
We, and our affiliates, are subject to a number of legal proceedings in various jurisdictions arising out of our operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. We review our legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follow appropriate accounting guidance when making accrual and disclosure decisions. We establish accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and disclose the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for our financial statements to not be misleading. We do not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, we believe that our liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to our financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.
37
The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in currency rates, commodity prices and interest rates. At times, we enter into contractual arrangements (derivatives) to reduce these exposures. For further information on our foreign currency derivative instruments, see Note 13 of Notes to Condensed Consolidated Financial Statements. As of
December 31, 2017
, there were no open derivative or hedging instruments for future purchases of raw materials or commodities. Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on LIBOR plus margin. As of
December 31, 2017
, our outstanding variable-rate debt included
$398.0
on our revolving credit facility in the U.S., $185.0 on our term loan and
$21.1
related to our international, variable-rate note payable. Assuming a one-percent increase in the applicable interest rates, annual interest expense on these variable-rate debt instruments would increase by approximately
$6.0
.
There have been no material changes in our assessment of market risk sensitivity since our presentation of "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K, as filed with the SEC on November 20, 2017.
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer ("CEO") and Interim Chief Financial Officer ("CFO"), as appropriate, to allow timely decisions regarding required disclosure.
Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of
December 31, 2017
. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended
December 31, 2017
that have materially affected, or are likely to materially affect, our internal control over financial reporting.
We, and our affiliates, are subject to a number of legal proceedings in various jurisdictions arising out of our operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. We review our legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follow appropriate accounting guidance when making accrual and disclosure decisions. We establish accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and disclose the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for our financial statements to not be misleading. We do not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, we believe that our liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to our financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.
Refer to Item 1A. Risk Factors in our Annual Report on Form 10-K for a detailed discussion of risk factors that could materially adversely affect our business, our operating results or our financial condition. The risk factor included below is a revision to one included in our Annual Report on Form 10-K.
38
Legislative changes in applicable tax laws, policies and regulations or unfavorable resolution of tax matters may result in additional tax liabilities, which could adversely impact our cash flows and results of operations.
Our businesses are subject to taxation in the U.S. and multiple foreign jurisdictions. On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The changes included in the Tax Act are broad and complex and the impact of the Tax Act is subject to change as a result of changes in interpretations of the Tax Act, legislative action to address questions that arise from the Tax Act, changes in accounting standards for income taxes or related interpretations, updates or changes to estimates of current year earnings, exchange rates and other factors. In addition, international tax reform remains a priority with the Organization for Economic Cooperation and Development’s Action Plan on Base Erosion & Profit Shifting and other proposed foreign jurisdictional tax law changes. Given the uncertainty of the possible changes and their potential interdependency, we are unable to determine whether the net consolidated impact of changes in global tax legislation would be positive or negative. However, the impact of any legislative tax law, policy or regulation changes by federal, state and local and foreign authorities may result in additional tax liabilities which could adversely impact our cash flows and results of operations.
Significant estimation and judgment is required in determining our provisions for taxes in the U.S. and jurisdictions outside the U.S. In the ordinary course of our business, there are transactions and calculations in which the ultimate tax determination is uncertain. We are regularly under audit by tax authorities, and although we believe our tax positions are defensible and our tax provision estimates are reasonable, the final outcome of tax audits and related litigation could be materially different than that reflected in our income tax provisions and accruals. The unfavorable resolution of any audits or litigation could have an adverse impact on future operating results and our financial condition. More aggressive and assertive tax collection policies, particularly in jurisdictions outside the U.S., may increase the costs of resolving tax issues and enhance the likelihood that we will have increased tax liabilities going forward.
39
The following table sets forth the purchases of the Company's securities by the Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3)) during the
first quarter
of fiscal 2018.
|
Period
|
Total Number of
Shares Purchased
(1) (2)
|
Average Price Paid
per share
(3)
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(2)
|
Maximum Number that May Yet Be Purchased Under the Plans or Programs
|
|||||||||
|
October 1 to 31, 2017
|
—
|
|
$
|
—
|
|
—
|
|
3,281,917
|
|
||||
|
November 1 to 30, 2017
|
1,033,815
|
|
59.14
|
|
1,000,000
|
|
2,281,917
|
|
|||||
|
December 1 to 31, 2017
|
932,882
|
|
60.10
|
|
932,796
|
|
1,349,121
|
|
|||||
|
(1)
|
33,901
shares purchased during the quarter relate to the surrender to the Company of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock equivalent awards.
|
|
(2)
|
In May 2015, the Company's Board of Directors approved an authorization to repurchase up to
ten million
shares of the Company's common stock. This authorization replaced a prior share repurchase authorization. During the
first quarter
of fiscal 2018, the Company repurchased
1,932,796
shares under this resolution.
|
|
(3)
|
Includes $0.02 per share of brokerage fee commissions.
|
None.
Not applicable.
None.
40
|
Exhibit Number
|
Exhibit
|
|
10.1
|
|
|
10.2
|
|
|
10.3
|
|
|
10.4
|
|
|
10.5
|
|
|
31.1
|
|
|
|
|
|
31.2
|
|
|
|
|
|
32.1
|
|
|
|
|
|
32.2
|
|
|
101
|
The following materials from the Edgewell Personal Care Company Quarterly Report on Form 10-Q formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Earnings and Comprehensive Income for the three months ended December 31, 2017 and 2016, (ii) the Condensed Consolidated Balance Sheets at December 31, 2017 and September 30, 2017, (iii) the Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2017 and 2016 and (iv) Notes to Condensed Consolidated Financial Statements. The financial information contained the XBRL-related documents is "unaudited" and "unreviewed."
|
41
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
EDGEWELL PERSONAL CARE COMPANY
|
||
|
|
|
||
|
|
Registrant
|
||
|
|
|
|
|
|
|
By:
|
/s/ Elizabeth E. Dreyer
|
|
|
|
|
Elizabeth E. Dreyer
|
|
|
|
|
Interim Chief Financial Officer
|
|
|
|
|
(on behalf of the Registrant and as principal financial officer)
|
|
|
|
|
||
|
Date:
|
February 8, 2018
|
|
|
42
TABLE OF CONTENTS
Part I - Financial InformationItem 1. Financial Statements (unaudited)Note 1 - Background and Basis Of PresentationNote 2 - DivestitureNote 3 - Restructuring ChargesNote 4 - Income TaxesNote 5 - Earnings Per ShareNote 6 - Goodwill and Intangible AssetsNote 7 - Supplemental Balance Sheet InformationNote 8 - Accounts Receivable FacilityNote 9 - DebtNote 10 - Retirement PlansNote 11 - Shareholders' EquityNote 12 - Accumulated Other Comprehensive (loss) IncomeNote 13 - Financial Instruments and Risk ManagementNote 14 - Commitments and ContingenciesNote 15 - Segment DataNote 16 - Guarantor and Non-guarantor Financial InformationNote 17 - Subsequent EventItem 2. Management's Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II - Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits